| Year |
Citation |
Score |
| 2023 |
Moulin D, Millard M, Taïeb M, Michaudel C, Aucouturier A, Lefèvre A, Bermúdez-Humarán LG, Langella P, Sereme Y, Wanherdrick K, Gautam P, Mariette X, Dieudé P, Gottenberg JE, Jouzeau JY, et al. Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis. Annals of the Rheumatic Diseases. PMID 38049981 DOI: 10.1136/ard-2023-224014 |
0.472 |
|
| 2023 |
Pezot M, Nocturne G, Belkhir R, Henry J, Pavy S, Seror R, Mariette X, Bitoun S. Obinutuzumab in patients with Sjogren's disease immunised against rituximab. Annals of the Rheumatic Diseases. PMID 37945315 DOI: 10.1136/ard-2023-224999 |
0.562 |
|
| 2023 |
Kachaner A, Bergé E, Desmoulins F, Le Pajolec C, Rousseau A, Labetoulle M, Nocturne G, Mariette X, Seror R. Comparison between primary Sjögren's disease patients with high or low level of dryness. Rmd Open. 9. PMID 37899092 DOI: 10.1136/rmdopen-2023-003291 |
0.565 |
|
| 2023 |
Nocturne G, Marmontel O, di Filippo M, Chretien P, Krzysiek R, Lifermann F, Rahal N, Belkhir R, Moulin P, Mariette X. Efficacy of daratumumab in refractory primary Sjögren disease. Rmd Open. 9. PMID 37730313 DOI: 10.1136/rmdopen-2023-003464 |
0.524 |
|
| 2023 |
Nguyen Y, Mariette X, Gottenberg JE, Iudici M, Morel J, Vittecoq O, Constantin A, Flipo RM, Schaeverbeke T, Sibilia J, Ravaud P, Porcher R, Seror R. Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry. Rheumatology (Oxford, England). PMID 37725356 DOI: 10.1093/rheumatology/kead495 |
0.732 |
|
| 2023 |
Paoletti A, Ly B, Cailleau C, Gao F, Péan de Ponfilly-Sotier M, Pascaud J, Rivière E, Yang L, Nwosu L, Elmesmari A, Reynaud F, Hita M, Paterson D, Reboud J, Fay F, ... ... Mariette X, et al. Liposomal AntagomiR-155-5p restores anti-inflammatory macrophages and improves arthritis in pre-clinical models of Rheumatoid arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 37527031 DOI: 10.1002/art.42665 |
0.561 |
|
| 2023 |
Devauchelle-Pensec V, Mariette X, Benyoussef AA, Boisrame S, Cochener B, Cornec D, Nocturne G, Gottenberg JE, Hachulla E, Labalette P, Le Guern V, M'Bwang Seppoh R, Morel J, Orliaguet M, Saraux A, et al. French national diagnostic and care protocol for Sjögren's disease. La Revue De Medecine Interne. 44: 423-457. PMID 37453854 DOI: 10.1016/j.revmed.2023.07.001 |
0.804 |
|
| 2023 |
Bitoun S, Hässler S, Ternant D, Szely N, Gleizes A, Richez C, Soubrier M, Avouac J, Brocq O, Sellam J, de Vries N, Huizinga TWJ, Jury EC, Manson JJ, Mauri C, ... ... Mariette X, et al. Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies. Jama Network Open. 6: e2323098. PMID 37436748 DOI: 10.1001/jamanetworkopen.2023.23098 |
0.479 |
|
| 2023 |
Nocturne G, Mariette X. Expert Perspective: Challenges in Sjögren's Disease. Arthritis & Rheumatology (Hoboken, N.J.). PMID 37229641 DOI: 10.1002/art.42612 |
0.541 |
|
| 2023 |
Duret PM, Schleiss C, Kawka L, Meyer N, Ye T, Saraux A, Devauchelle-Pensec V, Seror R, Larroche C, Perdriger A, Sibilia J, Vallat L, Fornecker LM, Nocturne G, Mariette X, et al. Bruton's tyrosine kinase (BTK) gene overexpression is associated with risk of lymphoma in primary Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 37115807 DOI: 10.1002/art.42550 |
0.566 |
|
| 2023 |
Chevalier K, Genin M, Jean TP, Avouac J, Flipo RM, Georgin-Lavialle S, El Mahou S, Pertuiset E, Pham T, Servettaz A, Marotte H, Domont F, Chazerain P, Devaux M, Mekinian A, ... ... Mariette X, et al. CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases. Frontiers in Medicine. 10: 1152587. PMID 37035330 DOI: 10.3389/fmed.2023.1152587 |
0.504 |
|
| 2023 |
Beydon M, Seror R, Le Guern V, Chretien P, Mariette X, Nocturne G. Impact of patient ancestry on heterogeneity of Sjögren's disease. Rmd Open. 9. PMID 36878621 DOI: 10.1136/rmdopen-2022-002955 |
0.585 |
|
| 2023 |
Rivière E, Chivasso C, Pascaud J, Bechara R, Ly B, Delporte C, Mariette X, Nocturne G. Hyperosmolar environment and salivary gland epithelial cells increase extra-cellular matrix remodeling and lymphocytic infiltration in Sjögren's syndrome. Clinical and Experimental Immunology. PMID 36759947 DOI: 10.1093/cei/uxad020 |
0.558 |
|
| 2023 |
Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi LA, Baecklund E, Brun JG, Bucher SM, Eloranta ML, Engelke F, Forsblad-d'Elia H, ... ... Mariette X, et al. Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells. Nature Communications. 14: 598. PMID 36737443 DOI: 10.1038/s41467-023-36369-4 |
0.53 |
|
| 2023 |
Nocturne G, Mariette X. Interferon signature in systemic autoimmune diseases: what does it mean? Rmd Open. 8. PMID 36597991 DOI: 10.1136/rmdopen-2022-002687 |
0.531 |
|
| 2022 |
Meudec L, Richebé P, Pascaud J, Mariette X, Nocturne G. Janus kinase inhibitors alter NK cells phenotype and inhibit their antitumor capacity. Rheumatology (Oxford, England). PMID 36583542 DOI: 10.1093/rheumatology/keac710 |
0.539 |
|
| 2022 |
Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi LA, Baecklund E, Brun JG, Bucher SM, Eloranta ML, Engelke F, Forsblad-d'Elia H, ... ... Mariette X, et al. Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells. Nature Communications. 13: 6519. PMID 36316359 DOI: 10.1038/s41467-022-34311-8 |
0.53 |
|
| 2022 |
Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, Alevizos I, Anaya JM, Aqrawi LA, Baecklund E, Brun JG, Bucher SM, Eloranta ML, Engelke F, Forsblad-d'Elia H, ... ... Mariette X, et al. Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells. Nature Communications. 13: 4287. PMID 35896530 DOI: 10.1038/s41467-022-30773-y |
0.542 |
|
| 2022 |
Urbain F, Ferlicot S, Rocher L, Besson FL, Gomez L, Michot JM, Lazure T, Mariette X, Nocturne G, Lambotte O, Zaidan M, Noel N. Renal involvement of lymphomas proven by kidney biopsy: report of 10 cases from a tertiary care center and comparison with the literature. International Journal of Hematology. PMID 35829895 DOI: 10.1007/s12185-022-03411-y |
0.547 |
|
| 2022 |
Trutschel D, Bost P, Mariette X, Bondet V, Llibre A, Posseme C, Charbit B, Thorball CW, Jonsson R, Lessard CJ, Felten R, Ng WF, Chatenoud L, Dumortier H, Sibilia J, et al. Variability in primary Sjögren's syndrome is driven by interferon alpha, and genetically associated with the class II HLA DQ locus. Arthritis & Rheumatology (Hoboken, N.J.). PMID 35726083 DOI: 10.1002/art.42265 |
0.754 |
|
| 2022 |
Da Cunha E, Mariette X, Desmoulins F, Bergé E, Nocturne G, Benmalek A, Haigh O, Seror R, Labetoulle M, Rousseau A. Associations between ocular and extra-ocular assessment in primary Sjögren's syndrome. Joint Bone Spine. 89: 105426. PMID 35716880 DOI: 10.1016/j.jbspin.2022.105426 |
0.58 |
|
| 2022 |
Bitoun S, Avouac J, Henry J, Ghossan R, Al Tabaa O, Belkhir R, Nocturne G, Mariaggi AA, Rozenberg F, Vauloup-Fellous C, Mariette X, Seror R. Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses. Rmd Open. 8. PMID 35589332 DOI: 10.1136/rmdopen-2022-002308 |
0.514 |
|
| 2022 |
Kedra J, Seror R, Dieudé P, Constantin A, Toussirot E, Kfoury E, Masson C, Cornec D, Dubost JJ, Marguerie L, Ottaviani S, Grados F, Belkhir R, Fain O, Fautrel B, ... ... Mariette X, et al. Lack of association between the TNFAIP3 rs2230926 variant and rheumatoid arthritis-associated lymphoma. Joint Bone Spine. 105390. PMID 35490943 DOI: 10.1016/j.jbspin.2022.105390 |
0.65 |
|
| 2022 |
Hermine O, Mariette X, Porcher R, Djossou F, Nguyen Y, Arlet JB, Savale L, Diehl JL, Georgin-Lavialle S, Cadranel J, Pialoux G, Lacombe K, Mekinian A, Gros H, Lescure X, et al. Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group. Eclinicalmedicine. 46: 101362. PMID 35350097 DOI: 10.1016/j.eclinm.2022.101362 |
0.716 |
|
| 2022 |
Paoletti A, Ly B, Bitoun S, Nocturne G, Rivière E, Manson JJ, Matucci A, Pallardy M, De Vries N, Mariette X. Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis. Frontiers in Immunology. 13: 832117. PMID 35281074 DOI: 10.3389/fimmu.2022.832117 |
0.548 |
|
| 2022 |
Hassold N, Seror R, Mariette X, Nocturne G. Characteristics of Sjögren's syndrome associated with rheumatoid arthritis. Rmd Open. 8. PMID 35177557 DOI: 10.1136/rmdopen-2022-002234 |
0.59 |
|
| 2022 |
Cachen L, Nocturne G, Collins M, Meyer A, Gleizes A, Hacein-Bey-Abina S, Carbonnel F, Mariette X, Seror R. Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF. Rmd Open. 8. PMID 35091460 DOI: 10.1136/rmdopen-2021-001697 |
0.579 |
|
| 2021 |
Parreau S, Nocturne G, Mariette X, Burroni B, Lazure T, Besson FL, Régent A, Mouthon L, Terrier B, Seror R, Le Guern V. Features of non-Hodgkin's lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren's syndrome patients. Rheumatology (Oxford, England). PMID 34940802 DOI: 10.1093/rheumatology/keab949 |
0.582 |
|
| 2021 |
Pean de Ponfilly-Sotier M, Besson FL, Gomez L, Ottaviani S, Dieudé P, Pavy S, Mariette X, Seror R, Nocturne G. Use of F FDG PET-CT to discriminate polymyalgia rheumatica and atypical spondylarthritis in clinical practice. Joint Bone Spine. 89: 105325. PMID 34915108 DOI: 10.1016/j.jbspin.2021.105325 |
0.474 |
|
| 2021 |
Rivière E, Pascaud J, Mariette X, Nocturne G. Response to «Are Salivary Gland Epithelial Cells the Main Source of Increased IL-7 in Primary Sjögren's Syndrome?» by Caiqun Chen et al. Arthritis & Rheumatology (Hoboken, N.J.). PMID 34694060 DOI: 10.1002/art.42004 |
0.551 |
|
| 2021 |
Kedra J, Seror R, Dieudé P, Constantin A, Toussirot E, Kfoury E, Masson C, Cornec D, Dubost JJ, Marguerie L, Ottaviani S, Grados F, Belkhir R, Fain O, Goupille P, ... ... Mariette X, et al. Lymphoma complicating rheumatoid arthritis: results from a French case-control study. Rmd Open. 7. PMID 34470830 DOI: 10.1136/rmdopen-2021-001698 |
0.671 |
|
| 2021 |
Bitoun S, Nocturne G, Seror R, Mariette X. Clinically effective concentration and risk of hydroxychloroquine retinopathy in Systemic Lupus Erythematosus : Walking on a thin line. Arthritis Care & Research. PMID 34459156 DOI: 10.1002/acr.24776 |
0.52 |
|
| 2021 |
Seror R, Nocturne G, Mariette X. Current and future therapies for primary Sjögren syndrome. Nature Reviews. Rheumatology. PMID 34188206 DOI: 10.1038/s41584-021-00634-x |
0.567 |
|
| 2021 |
Nocturne G, Ly B, Paoletti A, Pascaud J, Seror R, Nicco C, Mackay F, Vincent FB, Lazure T, Ferlicot S, Stimmer L, Pascal Q, Roulland S, Krzysiek R, Hacein-Bey S, ... ... Mariette X, et al. Long-term exposure to monoclonal anti-TNF is associated with an increased risk of lymphoma in BAFF-transgenic mice. Clinical and Experimental Immunology. PMID 33864242 DOI: 10.1111/cei.13602 |
0.573 |
|
| 2021 |
Kedra J, Nocturne G, Mariette X, Seror R. Inflammation-targeted therapies and cancer. Joint Bone Spine. 88: 105176. PMID 33771759 DOI: 10.1016/j.jbspin.2021.105176 |
0.516 |
|
| 2021 |
Dupré A, Pascaud J, Rivière E, Paoletti A, Ly B, Mingueneau M, Mariette X, Nocturne G. Association between T follicular helper cells and T peripheral helper cells with B-cell biomarkers and disease activity in primary Sjögren syndrome. Rmd Open. 7. PMID 33688082 DOI: 10.1136/rmdopen-2020-001442 |
0.574 |
|
| 2021 |
Bonnet I, Rousseau A, Duraffour P, Pouchot J, Nguyen CD, Gabison E, Seror R, Marotte H, Mariette X, Nocturne G. Efficacy and safety of rituximab in peripheral ulcerative keratitis associated with rheumatoid arthritis. Rmd Open. 7. PMID 33510042 DOI: 10.1136/rmdopen-2020-001472 |
0.562 |
|
| 2021 |
Martin de Fremont G, Chiron A, Krzysiek R, Hacein-Bey-Abina S, Mariette X, Nocturne G. Flare of a mixed cryoglobulinaemic vasculitis after obinutuzumab infusion. Clinical and Experimental Rheumatology. PMID 33506759 |
0.573 |
|
| 2020 |
Rivière E, Mariette X, Nocturne G. Response to: 'Role of interaction between B cells and epithelial cells in pSS' by Pringle . Annals of the Rheumatic Diseases. PMID 33060074 DOI: 10.1136/annrheumdis-2020-219096 |
0.529 |
|
| 2020 |
Rivière E, Pascaud J, Virone A, Dupré A, Ly B, Paoletti A, Seror R, Tchitchek N, Mingueneau M, Smith N, Duffy D, Cassard L, Chaput N, Pengam S, Gauttier V, ... ... Mariette X, et al. Interleukin-7/Interferon axis drives T-cell and salivary gland epithelial cell interactions in Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 33058491 DOI: 10.1002/art.41558 |
0.57 |
|
| 2020 |
Brito-Zerón P, Pasoto SG, Robles-Marhuenda A, Mandl T, Vissink A, Armagan B, Praprotnik S, Nocturne G, Sebastian A, Fernandes Moça Trevisani V, Retamozo S, Acar-Denizli N, Wiland P, Sisó-Almirall A, Bootsma H, ... Mariette X, et al. Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases. Clinical and Experimental Rheumatology. PMID 33025893 |
0.544 |
|
| 2020 |
Blanchet B, Jallouli M, Allard M, Ghillani-Dalbin P, Galicier L, Aumaître O, Chasset F, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, ... ... Mariette X, et al. Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence. Arthritis Research & Therapy. 22: 223. PMID 32977856 DOI: 10.1186/s13075-020-02291-z |
0.434 |
|
| 2020 |
Rivière E, Pascaud J, Tchitchek N, Boudaoud S, Paoletti A, Ly B, Dupré A, Chen H, Thai A, Allaire N, Jagla B, Mingueneau M, Nocturne G, Mariette X. Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation. Annals of the Rheumatic Diseases. PMID 32843324 DOI: 10.1136/Annrheumdis-2019-216588 |
0.633 |
|
| 2020 |
Courvoisier DS, Chatzidionysiou K, Mongin D, Lauper K, Mariette X, Morel J, Gottenberg JE, Bergstra SA, Suarez MP, Codreanu C, Kvien TK, Santos MJ, Pavelka K, Hetland ML, Askling J, et al. The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries. Rheumatology (Oxford, England). PMID 32810263 DOI: 10.1093/Rheumatology/Keaa393 |
0.305 |
|
| 2020 |
Chevalier K, Belkhir R, Seror R, Mariette X, Nocturne G. Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone. Annals of the Rheumatic Diseases. PMID 32398282 DOI: 10.1136/Annrheumdis-2020-217481 |
0.637 |
|
| 2020 |
Dupré A, Collins M, Nocturne G, Carbonnel F, Mariette X, Seror R. Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab. Rheumatology (Oxford, England). PMID 32259251 DOI: 10.1093/rheumatology/keaa107 |
0.575 |
|
| 2020 |
Martin de Fremont G, Belkhir R, Henry J, Voisin AL, Lambotte O, Besson FL, Mariette X, Nocturne G. Features of polymyalgia rheumatica-like syndrome after immune checkpoint inhibitor therapy. Annals of the Rheumatic Diseases. PMID 32188691 DOI: 10.1136/annrheumdis-2020-217225 |
0.527 |
|
| 2020 |
Dörner T, Bowman SJ, Fox R, Mariette X, Papas A, Grader-Beck T, Fisher BA, Barcelos F, Vita SD, Schulze-Koops H, Moots RJ, Junge G, Woznicki J, Sopala M, Luo WL, et al. Op0302 Ianalumab (Vay736), A Dual Mode Of Action Biologic Combining Baff Receptor Inhibition With B Cell Depletion, Reaches Primary Endpoint For Treatment Of Primary Sjogren’S Syndrome Annals of the Rheumatic Diseases. 79: 187-188. DOI: 10.1136/Annrheumdis-2020-Eular.364 |
0.32 |
|
| 2020 |
Cachen L, Nocturne G, Collins M, Meyer A, Carbonnel F, Mariette X, Seror R. Thu0382 Articular Manifestations In Patients With Inflammatory Bowel Diseases Treated With Anti-Tnfα Annals of the Rheumatic Diseases. 79: 425-425. DOI: 10.1136/Annrheumdis-2020-Eular.2563 |
0.632 |
|
| 2019 |
Brito-Zerón P, Acar-Denizli N, Ng WF, Horváth IF, Rasmussen A, Seror R, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, ... ... Mariette X, et al. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome. Rheumatology (Oxford, England). PMID 31873754 DOI: 10.1093/Rheumatology/Kez578 |
0.348 |
|
| 2019 |
Leite Pereira A, Bitoun S, Paoletti A, Nocturne G, Marcos Lopez E, Cosma A, Le Grand R, Mariette X, Tchitchek N. Characterization of Phenotypes and Functional Activities of Leukocytes From Rheumatoid Arthritis Patients by Mass Cytometry. Frontiers in Immunology. 10: 2384. PMID 31681279 DOI: 10.3389/Fimmu.2019.02384 |
0.624 |
|
| 2019 |
Baber A, Nocturne G, Krzysiek R, Henry J, Belkhir R, Mariette X, Seror R. Large granular lymphocyte expansions in primary Sjögren's syndrome: characteristics and outcomes. Rmd Open. 5: e001044. PMID 31673421 DOI: 10.1136/Rmdopen-2019-001044 |
0.59 |
|
| 2019 |
Abbara S, Seror R, Henry J, Chretien P, Gleizes A, Hacein-Bey-Abina S, Mariette X, Nocturne G. Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement. Rmd Open. 5: e001033. PMID 31673417 DOI: 10.1136/Rmdopen-2019-001033 |
0.624 |
|
| 2019 |
Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, ... ... Mariette X, et al. EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. Annals of the Rheumatic Diseases. PMID 31672775 DOI: 10.1136/Annrheumdis-2019-216114 |
0.309 |
|
| 2019 |
Nocturne G, Pascaud J, Ly B, Tahmasebi F, Mariette X. JAK inhibitors alter NK cell functions and may impair immunosurveillance against lymphomagenesis. Cellular & Molecular Immunology. PMID 31664224 DOI: 10.1038/s41423-019-0320-3 |
0.501 |
|
| 2019 |
Combier A, Nocturne G, Henry J, Belkhir R, Pavy S, Le Tiec C, Descamps E, Seror R, Mariette X. Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy. Rheumatology (Oxford, England). PMID 31613955 DOI: 10.1093/Rheumatology/Kez430 |
0.606 |
|
| 2019 |
Assan F, Seror R, Mariette X, Nocturne G. New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS. Annals of the Rheumatic Diseases. PMID 31501139 DOI: 10.1136/annrheumdis-2019-216222 |
0.554 |
|
| 2019 |
Paoletti A, Rohmer J, Ly B, Pascaud J, Rivière E, Seror R, Le Goff B, Nocturne G, Mariette X. Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors. Journal of Immunology (Baltimore, Md. : 1950). PMID 31484730 DOI: 10.4049/Jimmunol.1900386 |
0.595 |
|
| 2019 |
Curtis JR, Mariette X, Gaujoux-Viala C, Blauvelt A, Kvien TK, Sandborn WJ, Winthrop K, de Longueville M, Huybrechts I, Bykerk VP. Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials. Rmd Open. 5: e000942. PMID 31245056 DOI: 10.1136/Rmdopen-2019-000942 |
0.326 |
|
| 2019 |
Bodewes ILA, Gottenberg JE, van Helden-Meeuwsen CG, Mariette X, Versnel MA. Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren's syndrome in the JOQUER randomized trial. Rheumatology (Oxford, England). PMID 31237947 DOI: 10.1093/Rheumatology/Kez242 |
0.344 |
|
| 2019 |
Hillion J, Bellier A, Romand X, Fautrel B, Mariette X, Sagéloli F, Baillet A, Gaudin P. Alcohol is not the missing link between -related periodontitis and radiological progression in early rheumatoid arthritis: comment on ' experimentally induces periodontitis and an anti-CCP2-associated arthritis in the rat'. Annals of the Rheumatic Diseases. PMID 31201174 DOI: 10.1136/Annrheumdis-2019-215603 |
0.333 |
|
| 2019 |
Sanosyan A, Daien C, Nutz A, Bollore K, Bedin AS, Morel J, Zimmermann V, Nocturne G, Peries M, Guigue N, Gottenberg JE, Van de Perre P, Mariette X, Tuaillon E. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome. Frontiers in Immunology. 10: 1153. PMID 31191532 DOI: 10.3389/Fimmu.2019.01153 |
0.642 |
|
| 2019 |
Bitoun S, Roques P, Maillere B, Le Grand R, Mariette X. Valine 11 and phenylalanine 13 have a greater impact on the T-cell response to citrullinated peptides than the 70-74 shared epitope of the DRB1 molecule in macaques. Annals of the Rheumatic Diseases. PMID 31023654 DOI: 10.1136/Annrheumdis-2019-215114 |
0.304 |
|
| 2019 |
Gossec L, Fayet F, Soubrier M, Foissac F, Molto A, Richette P, Beauvais C, Ruyssen-Witrand A, Perdriger A, Chary-Valckenaere I, Mouterde G, Dernis E, Euller-Ziegler L, Flipo RM, Gilson M, ... ... Mariette X, et al. Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients. Rheumatology (Oxford, England). PMID 30915463 DOI: 10.1093/Rheumatology/Kez094 |
0.31 |
|
| 2019 |
Anquetil C, Hachulla E, Machuron F, Mariette X, Hatron PY. Comment on: Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease? Reply. Rheumatology (Oxford, England). PMID 30859229 DOI: 10.1093/Rheumatology/Kez074 |
0.329 |
|
| 2019 |
Nocturne G, Pontarini E, Bombardieri M, Mariette X. Lymphomas complicating primary Sjögren's syndrome: from autoimmunity to lymphoma. Rheumatology (Oxford, England). PMID 30838413 DOI: 10.1093/Rheumatology/Kez052 |
0.63 |
|
| 2019 |
Gottenberg JE, Morel J, Perrodeau E, Bardin T, Combe B, Dougados M, Flipo RM, Saraux A, Schaeverbeke T, Sibilia J, Soubrier M, Vittecoq O, Baron G, Constantin A, Ravaud P, ... Mariette X, et al. Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study. Bmj (Clinical Research Ed.). 364: l67. PMID 30679233 DOI: 10.1136/Bmj.L67 |
0.315 |
|
| 2019 |
Keraen J, Blanc E, Besson FL, Leguern V, Meyer C, Henry J, Belkhir R, Nocturne G, Mariette X, Seror R. Usefulness of F-FDG Positron Emission Tomography (PET) for the diagnosis of lymphoma in primary Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 30615273 DOI: 10.1002/Art.40829 |
0.561 |
|
| 2019 |
Marinello D, Ticciati S, Talarico R, Alexander T, Arnaud L, Cavagna L, Beretta L, Chaigne B, Cornet A, Costedoat-Chalumeau N, Fischer-Betz R, Frank CH, Galetti I, Grunert J, Guimaraes V, ... ... Mariette X, et al. Fri0607 Identification Of Unmet Needs Related To Rare And Complex Connective Tissue And Musculoskeletal Diseases (Rctds) Across Eu: The Experience Of The Ern Reconnet Annals of the Rheumatic Diseases. 78: 999-999. DOI: 10.1136/Annrheumdis-2019-Eular.7558 |
0.303 |
|
| 2019 |
Paoletti A, Reynaud F, Rohmer J, Pascaud J, Ly B, Rivière E, Tsapis N, Fattal E, Nocturne G, Mariette X. Sat0057 Increased Microrna-155 Is Associated With A Specific Defect Of Anti-Inflammatory M2 Macrophages Polarization Both In Human Rheumatoid Arthritis And In Collagen-Induced-Arthritis Mice Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.5415 |
0.586 |
|
| 2019 |
Bykerk V, Blauvelt A, Curtis J, Gaujoux-Viala C, Kvien TK, Sandborn W, Winthrop K, Popova C, Mariette X. Sat0605 Body Mass Index And Systemic Corticosteroid Use As Indicators Of Disease Burden And Their Influence On The Safety Profile Of Certolizumab Pegol Across Indications Annals of the Rheumatic Diseases. 78: 1396-1397. DOI: 10.1136/Annrheumdis-2019-Eular.496 |
0.312 |
|
| 2019 |
Juarez M, Diaz N, Johnston GI, Nayar S, Payne A, Helmer E, Cain D, Williams P, Ng WF, Fisher B, Gottenberg J, Guggino G, Mariette X, Kvarnström M, Devauchelle-Pensec V, et al. Ab0458 A Phase Ii Randomised, Double-Blind, Placebo-Controlled, Proof Of Concept Study Of Oral Seletalisib In Patients With Primary Sjögren’S Syndrome (Pss) Annals of the Rheumatic Diseases. 78: 1692-1693. DOI: 10.1136/Annrheumdis-2019-Eular.4887 |
0.333 |
|
| 2019 |
Rivière E, Pascaud J, Tchitchek N, Boudaoud S, Paoletti A, Ly B, Thai A, Allaire N, Jagla B, Mingueneau M, Nocturne G, Mariette X. Ab0190 Crosstalk Between Salivary Gland Epithelial Cells And B Lymphocytes In Primary Sjögren’S Syndrome Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.4121 |
0.616 |
|
| 2019 |
Dupré A, Collins M, Carbonnel F, Mariette X, Nocturne G, Seror R. Sat0324 Articular Manifestations In Patients With Inflammatory Bowel Disease Treated With Vedolizumab Annals of the Rheumatic Diseases. 78: 1240-1241. DOI: 10.1136/Annrheumdis-2019-Eular.3969 |
0.612 |
|
| 2019 |
Combier A, Nocturne G, Henry J, Belkhir R, Pavy S, Mariette X, Seror R. Ab0462 Immunizationto Rituximab Is More Frequent In Autoimmune Systemic Autoimmune Diseases Than In Rheumatoid Arthritis And May Be Managed By Switching From Rituximab To Ofatumumab Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.3343 |
0.599 |
|
| 2019 |
Retamozo S, Acar-Denizli N, Ng WF, Horváth IF, Rasmussen A, Seror R, Xiaomei L, Baldini C, Gottenberg J, Sandhya P, Quartuccio L, Priori R, Hernandez-Molina G, Armagan B, Kruize AA, ... ... Mariette X, et al. Ab0550 Phenotype Of Biopsy-Proven Patients With Primary Sjögren Syndrome Lacking Ro Autoantibodies: High Frequency Of Dryness Symptoms With Low Systemic Activity (Big Data Sjögren Project) Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.2259 |
0.305 |
|
| 2019 |
Szafors P, Lukas C, Gottenberg J, Mariette X, Combe B, Morel J. Sat0179 Change In Immunological Parameters During Follow-Up Of Patients With Primary Sjögren’S Syndrome: Data From The French Assess Cohort Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2019-Eular.2241 |
0.312 |
|
| 2019 |
Paoletti A, Rohmer J, Ly B, Pascaud J, Riviere E, Nocturne G, Mariette X. P034 Presence of a specific defect in M2 polarization of blood monocytes from patients with rheumatoid arthritis, associated with increased microRNA-155 Annals of the Rheumatic Diseases. 78. DOI: 10.1136/Annrheumdis-2018-Ewrr2019.26 |
0.581 |
|
| 2019 |
Mariette X, Schaeverbeke T, Gaudin P, Chartier M, Heitzmann J, Vannier-Moreau V, Hilliquin P, Cantagrel A. Maintien thérapeutique à deux ans de l’abatacept en pratique courante. Résultats de la cohorte française de l’étude ACTION Revue Du Rhumatisme. 86: 483-489. DOI: 10.1016/J.Rhum.2019.06.009 |
0.301 |
|
| 2019 |
Cordel N, Aussy A, Derambure C, Coutant S, Mariette X, Jullien D, Debarbieux S, Chosidow O, Beneveniste O, Meyer A, Bessis D, Joly P, Levesque H, Tournier I, Boyer O. Étude des mutations somatiques tumorales du gène codant pour la protéine TIF1 gamma chez les patients présentant une dermatomyosite TIF1 gamma positive avec cancer associé Annales De Dermatologie Et De VéNéRéOlogie. 146: A78. DOI: 10.1016/J.Annder.2019.09.066 |
0.307 |
|
| 2018 |
Magill L, Adriani M, Berthou V, Chen K, Gleizes A, Hacein-Bey-Abina S, Hincelin-Mery A, Mariette X, Pallardy M, Spindeldreher S, Szely N, Isenberg DA, Manson JJ, Jury EC, Mauri C. Low Percentage of Signal Regulatory Protein α/β Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients. Frontiers in Immunology. 9: 2865. PMID 30568660 DOI: 10.3389/Fimmu.2018.02865 |
0.361 |
|
| 2018 |
Anquetil C, Hachulla E, Machuron F, Mariette X, Le Guern V, Vittecoq O, Dernis E, Larroche C, Dubost JJ, Perdriger A, Devauchelle-Pensec V, Fauchais AL, Morel J, Dieudé P, Rist S, et al. Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease? Rheumatology (Oxford, England). PMID 30561748 DOI: 10.1093/Rheumatology/Key392 |
0.31 |
|
| 2018 |
Quistrebert J, Hässler S, Bachelet D, Mbogning C, Musters A, Tak PP, Wijbrandts CA, Herenius M, Bergstra SA, Akdemir G, Johannesson M, Combe B, Fautrel B, Chollet-Martin S, Gleizes A, ... ... Mariette X, et al. Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis. Seminars in Arthritis and Rheumatism. PMID 30420245 DOI: 10.1016/J.Semarthrit.2018.10.006 |
0.327 |
|
| 2018 |
Mirouse A, Seror R, Vicaut E, Mariette X, Dougados M, Fauchais AL, Deroux A, Dellal A, Costedoat-Chalumeau N, Denis G, Sellam J, Arlet JB, Lavigne C, Urbanski G, Fischer-Dumont D, et al. Arthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study. Autoimmunity Reviews. PMID 30408585 DOI: 10.1016/J.Autrev.2018.06.015 |
0.543 |
|
| 2018 |
Romão VC, Talarico R, Scirè CA, Vieira A, Alexander T, Baldini C, Gottenberg JE, Gruner H, Hachulla E, Mouthon L, Orlandi M, Pamfil C, Pineton de Chambrun M, Taglietti M, Toplak N, ... ... Mariette X, et al. Sjögren's syndrome: state of the art on clinical practice guidelines. Rmd Open. 4: e000789. PMID 30402274 DOI: 10.1136/Rmdopen-2018-000789 |
0.338 |
|
| 2018 |
Daien C, Hua C, Gaujoux-Viala C, Cantagrel A, Dubremetz M, Dougados M, Fautrel B, Mariette X, Nayral N, Richez C, Saraux A, Thibaud G, Wendling D, Gossec L, Combe B. Update of French Society for Rheumatology Recommendations for Managing Rheumatoid Arthritis. Joint, Bone, Spine : Revue Du Rhumatisme. PMID 30315988 DOI: 10.1016/J.Jbspin.2018.10.002 |
0.314 |
|
| 2018 |
Park JK, Lee YJ, Bitoun S, Winthrop KL, Choi Y, Lee EB, Mariette X. Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. PMID 30297326 DOI: 10.1136/Annrheumdis-2018-214025 |
0.362 |
|
| 2018 |
Nocturne G, Seror R, Mariette X. Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands? Annals of the Rheumatic Diseases. PMID 30030264 DOI: 10.1136/Annrheumdis-2018-213979 |
0.605 |
|
| 2018 |
Bitoun S, Miceli-Richard C, Verstuyft C, Juge PA, Dieudé P, Berthelot JM, Richez C, Cauquil C, Sordet C, Melac-Ducamp S, Gossec L, Bouvard B, Dernis E, Houvenagel E, Boutry-Bacle MA, ... Mariette X, et al. Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications. Annals of the Rheumatic Diseases. PMID 30030263 DOI: 10.1136/Annrheumdis-2018-213183 |
0.577 |
|
| 2018 |
Bitoun S, Nocturne G, Ly B, Krzysiek R, Roques P, Pruvost A, Paoletti A, Pascaud J, Dönnes P, Florence K, Gleizes A, Hincelin-Mery A, Allez M, Hacein-Bey-Abina S, Mackay F, ... ... Mariette X, et al. Methotrexate and BAFF interaction prevents immunization against TNF inhibitors. Annals of the Rheumatic Diseases. PMID 29936438 DOI: 10.1136/Annrheumdis-2018-213403 |
0.599 |
|
| 2018 |
Rivière E, Sellam J, Pascaud J, Ravaud P, Gottenberg JE, Mariette X. Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis. Arthritis Research & Therapy. 20: 122. PMID 29884223 DOI: 10.1186/S13075-018-1628-6 |
0.539 |
|
| 2018 |
Michot JM, Fusellier M, Champiat S, Velter C, Baldini C, Voisin AL, Danlos FX, Dakdouki YE, Annereau M, Mariette X, Robert C, Cherif K, Marabelle A, Mateus C, Lambotte O. Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1. Annals of the Rheumatic Diseases. PMID 29858173 DOI: 10.1136/Annrheumdis-2018-213677 |
0.316 |
|
| 2018 |
Mariette X, Criswell LA. Primary Sjögren's Syndrome. The New England Journal of Medicine. 378: 931-939. PMID 29514034 DOI: 10.1056/Nejmcp1702514 |
0.374 |
|
| 2018 |
Demaria L, Henry J, Seror R, Frenzel L, Hermine O, Mariette X, Nocturne G. Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sjögren syndrome (pSS). British Journal of Haematology. PMID 29424433 DOI: 10.1111/Bjh.15120 |
0.581 |
|
| 2018 |
Nocturne G, Mariette X. B cells in the pathogenesis of primary Sjögren syndrome. Nature Reviews. Rheumatology. PMID 29416129 DOI: 10.1038/Nrrheum.2018.1 |
0.616 |
|
| 2018 |
Gottenberg JE, Dörner T, Bootsma H, Devauchelle-Pensec V, Bowman SJ, Mariette X, Bartz H, Oortgiesen M, Shock A, Koetse W, Galateanu C, Bongardt S, Wegener WA, Goldenberg DM, Meno-Tetang G, et al. Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients with Associated Sjögren's Syndrome: Post-hoc Analyses from the EMBODY Trials. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29381843 DOI: 10.1002/Art.40425 |
0.352 |
|
| 2018 |
Rivière E, Tchitchek N, Nocturne G, Pascaud J, Boudaoud S, Thai A, Allaire N, Jagla B, Mingueneau M, Mariette X. P071/O13 RNA sequencing detection of gene dysregulation in B cells sorted from salivary gland tissue and from peripheral blood reveals new pathways involved in primary sjÖgren’s syndrome pathophysiology Annals of the Rheumatic Diseases. 77: 138-138. DOI: 10.1136/Annrheumdis-2018-Ewrr2019.60 |
0.611 |
|
| 2018 |
Bitoun S, Nocturne G, Ly B, Krzysiek R, Pruvost A, Paoletti A, Pascaud J, Dönnes P, Florence K, Gleizes A, Hincelin-Mery A, Allez M, Bey SH, Pallardy M, Mariette X. P008 Methotrexate and baff interaction prevents immunisation against TNF-Α inhibitors by increasing adenosine and regulatory B-cells Annals of the Rheumatic Diseases. 77. DOI: 10.1136/Annrheumdis-2018-Ewrr2018.34 |
0.617 |
|
| 2018 |
Virone A, Pascaud J, Riviere E, Gottenberg J, Guern VL, Mariette X, Nocturne G. O017 Il-7 in primary sjÖgren syndrome (PSS) is secreted by salivary gland epithelial cells after ifn stimulation and is associated with B-cell activation Annals of the Rheumatic Diseases. 77. DOI: 10.1136/Annrheumdis-2018-Ewrr2018.17 |
0.58 |
|
| 2018 |
Aringer M, Costenbader KH, Brinks R, Boumpas D, Daikh D, Jayne D, Kamen D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Diamond B, Jacobsen S, McCune WJ, Ruiz-Irastorza G, ... ... Mariette X, et al. OP0020 Validation of new systemic lupus erythematosus classification criteria Annals of the Rheumatic Diseases. 77: 60-60. DOI: 10.1136/Annrheumdis-2018-Eular.3679 |
0.31 |
|
| 2018 |
Rivière E, Tchitchek N, Nocturne G, Boudaoud S, Pascaud J, Virone A, Thai A, Allaire N, Jagla B, Mingueneau M, Mariette X. FRI0273 Rna sequencing detection of gene dysregulation in epithelial sorted cells from salivary gland tissue reveals interesting pathways involved in sjÖgren’s syndrome pathophysiology Annals of the Rheumatic Diseases. 77: 675-675. DOI: 10.1136/Annrheumdis-2018-Eular.3307 |
0.622 |
|
| 2018 |
Sigaux J, Hamze M, Daien C, Morel J, Krzysiek R, Pallardy M, Maillere B, Mariette X, Miceli-Richard C. Immunogénicité du tocilizumab chez des patients atteints de polyarthrite rhumatoïde Revue Du Rhumatisme. 85: 54-60. DOI: 10.1016/J.Rhum.2017.07.005 |
0.583 |
|
| 2018 |
Ménage-Anjuère C, Ayçaguer S, Rieutord A, Mariette X, Seror R. ATÉLIER ETP2 > Le SÉSAME Quiz : évaluer les acquis des patients en éducation thérapeutique du patient par le numérique Revue Neurologique. 174: S171. DOI: 10.1016/J.Neurol.2018.02.031 |
0.308 |
|
| 2017 |
Bitoun S, Roques P, Larcher T, Nocturne G, Serguera C, Chrétien P, Serre G, Grand RL, Mariette X. Both Systemic and Intra-articular Immunization with Citrullinated Peptides Are Needed to Induce Arthritis in the Macaque. Frontiers in Immunology. 8: 1816. PMID 29326703 DOI: 10.3389/Fimmu.2017.01816 |
0.594 |
|
| 2017 |
Henry J, Gottenberg JE, Rouanet S, Pavy S, Sellam J, Tubach F, Belkhir R, Mariette X, Seror R. Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infection. Rheumatology (Oxford, England). PMID 29267905 DOI: 10.1093/Rheumatology/Kex446 |
0.505 |
|
| 2017 |
Harris VM, Sharma R, Cavett J, Kurien BT, Liu K, Koelsch KA, Rasmussen A, Radfar L, Lewis D, Stone DU, Kaufman CE, Li S, Segal B, Wallace DJ, Weisman MH, ... ... Mariette X, et al. Corrigendum to "Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome" [Clin. Immunol. 168 (2016) 25-29]. Clinical Immunology (Orlando, Fla.). PMID 29195081 DOI: 10.1016/J.Clim.2017.11.012 |
0.568 |
|
| 2017 |
Juge PA, Gazal S, Constantin A, Mariette X, Combe B, Tebib J, Dougados M, Sibilia J, Le Loet X, Dieudé P. Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis. Rmd Open. 3: e000448. PMID 29071117 DOI: 10.1136/Rmdopen-2017-000448 |
0.318 |
|
| 2017 |
Seror R, Mariette X. Guidelines for treatment of primary Sjögren's syndrome: a first useful stone but still much to do. Rheumatology (Oxford, England). 56: 1641-1642. PMID 28957571 DOI: 10.1093/Rheumatology/Kex320 |
0.302 |
|
| 2017 |
Morel J, Constantin A, Baron G, Dernis E, Flipo RM, Rist S, Combe B, Gottenberg JE, Schaeverbeke T, Soubrier M, Vittecoq O, Dougados M, Saraux A, Mariette X, Ravaud P, et al. Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE. Rheumatology (Oxford, England). 56: 1746-1754. PMID 28957557 DOI: 10.1093/Rheumatology/Kex238 |
0.755 |
|
| 2017 |
Sigaux J, Bailly F, Hajage D, Mariette X, Morel J, Gandjbakhch F, Foltz V, Gossec L, Tubach F, Fautrel B. Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial. Rmd Open. 3: e000474. PMID 28955495 DOI: 10.1136/Rmdopen-2017-000474 |
0.321 |
|
| 2017 |
Wang-Renault SF, Boudaoud S, Nocturne G, Roche E, Sigrist N, Daviaud C, Bugge Tinggaard A, Renault V, Deleuze JF, Mariette X, Tost J. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. PMID 28916716 DOI: 10.1136/Annrheumdis-2017-211417 |
0.604 |
|
| 2017 |
Fogel O, Rivière E, Seror R, Nocturne G, Boudaoud S, Ly B, Gottenberg JE, Le Guern V, Dubost JJ, Nititham J, Taylor KE, Chanson P, Dieudé P, Criswell LA, Jagla B, ... ... Mariette X, et al. Role of the IL-12/IL-35 balance in Sjögren's syndrome. The Journal of Allergy and Clinical Immunology. PMID 28916184 DOI: 10.1016/J.Jaci.2017.07.041 |
0.679 |
|
| 2017 |
Mariette X. Certolizumab, an anti-TNF safe during pregancy? The CRIB Study results: an interview with Professor Xavier Mariette. Immunotherapy. 9: 793-795. PMID 28877634 DOI: 10.2217/Imt-2017-0099 |
0.38 |
|
| 2017 |
Mercer LK, Regierer AC, Mariette X, Dixon WG, Baecklund E, Hellgren K, Dreyer L, Hetland ML, Cordtz R, Hyrich K, Strangfeld A, Zink A, Canhao H, Hernandez MV, Tubach F, et al. Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project. Annals of the Rheumatic Diseases. PMID 28822981 DOI: 10.1136/Annrheumdis-2017-211623 |
0.326 |
|
| 2017 |
Winthrop KL, Strand V, van der Heijde D, Mease P, Crow M, Weinblatt M, Bathon J, Burmester GR, Dougados M, Kay J, Mariette X, Van Vollenhoven R, Sieper J, Melchers F, Breedfeld FC, et al. The unmet need in rheumatology: Reports from the targeted therapies meeting 2017. Clinical Immunology (Orlando, Fla.). PMID 28811201 DOI: 10.1016/J.Clim.2017.08.009 |
0.307 |
|
| 2017 |
Sharma R, Harris VM, Cavett J, Kurien BT, Liu K, Koelsch KA, Fayaaz A, Chaudhari KS, Radfar L, Lewis D, Stone DU, Kaufman CE, Li S, Segal B, Wallace DJ, ... ... Mariette X, et al. Rare X chromosome abnormalities in systemic lupus erythematosus and Sjögren's syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 28692793 DOI: 10.1002/Art.40207 |
0.562 |
|
| 2017 |
Weinblatt ME, Bingham CO, Burmester GR, Bykerk VP, Furst DE, Mariette X, van der Heijde D, van Vollenhoven R, Van Lunen B, Ecoffet C, Cioffi C, Emery P. A Phase 3 Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol after 1 Year of Therapy in Early Rheumatoid Arthritis Patients. Arthritis & Rheumatology (Hoboken, N.J.). PMID 28666080 DOI: 10.1002/Art.40196 |
0.3 |
|
| 2017 |
Li H, Reksten TR, Ice JA, Kelly JA, Adrianto I, Rasmussen A, Wang S, He B, Grundahl KM, Glenn SB, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, ... ... Mariette X, et al. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. Plos Genetics. 13: e1006820. PMID 28640813 DOI: 10.1371/Journal.Pgen.1006820 |
0.591 |
|
| 2017 |
Belkhir R, Burel SL, Dunogeant L, Marabelle A, Hollebecque A, Besse B, Leary A, Voisin AL, Pontoizeau C, Coutte L, Pertuiset E, Mouterde G, Fain O, Lambotte O, Mariette X. Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment. Annals of the Rheumatic Diseases. PMID 28600350 DOI: 10.1136/Annrheumdis-2017-211216 |
0.301 |
|
| 2017 |
Hamze M, Meunier S, Karle A, Gdoura A, Goudet A, Szely N, Pallardy M, Carbonnel F, Spindeldreher S, Mariette X, Miceli-Richard C, Maillère B. Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors. Frontiers in Immunology. 8: 500. PMID 28529511 DOI: 10.3389/Fimmu.2017.00500 |
0.566 |
|
| 2017 |
Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, ... ... Mariette X, et al. International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus. Autoimmunity Reviews. PMID 28434948 DOI: 10.1016/J.Autrev.2017.04.011 |
0.509 |
|
| 2017 |
Rivière E, Arnaud L, Ebbo M, Allanore Y, Claudepierre P, Dernis E, Ziza JM, Miceli-Richard C, Philippe P, Richez C, Soubrier M, Belkhir R, Seror R, Mariette X, Pavy S, et al. Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases. The Journal of Rheumatology. PMID 28412700 DOI: 10.3899/Jrheum.160762 |
0.545 |
|
| 2017 |
Vanier A, Mariette X, Tubach F, Fautrel B. Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission: An Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis Trial. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 20: 577-585. PMID 28407999 DOI: 10.1016/J.Jval.2017.01.005 |
0.324 |
|
| 2017 |
Carapito R, Gottenberg JE, Kotova I, Untrau M, Michel S, Naegely L, Aouadi I, Kwemou M, Paul N, Pichot A, Locke J, Bowman SJ, Griffiths B, Sivils KL, Sibilia J, ... ... Mariette X, et al. A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA. Human Molecular Genetics. PMID 28379387 DOI: 10.1093/Hmg/Ddx135 |
0.598 |
|
| 2017 |
de Jong TD, Sellam J, Agca R, Vosslamber S, Witte BI, Tsang-A-Sjoe M, Mantel E, Bijlsma JW, Voskuyl AE, Nurmohamed MT, Verweij CL, Mariette X. A multi-parameter response prediction model for rituximab in rheumatoid arthritis. Joint, Bone, Spine : Revue Du Rhumatisme. PMID 28363827 DOI: 10.1016/J.Jbspin.2017.02.015 |
0.504 |
|
| 2017 |
Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, ... ... Mariette X, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the Rheumatic Diseases. PMID 28264816 DOI: 10.1136/Annrheumdis-2016-210715 |
0.321 |
|
| 2017 |
Alten R, Nüßlein HG, Mariette X, Galeazzi M, Lorenz HM, Cantagrel A, Chartier M, Poncet C, Rauch C, Le Bars M. Baseline autoantibodies preferentially impact abatacept efficacy in patients with rheumatoid arthritis who are biologic naïve: 6-month results from a real-world, international, prospective study. Rmd Open. 3: e000345. PMID 28243468 DOI: 10.1136/Rmdopen-2016-000345 |
0.332 |
|
| 2017 |
Nocturne G, Seror R, Devauchelle-Pensec V, Saraux A, Mariette X, Chiche L. Prevalence of primary Sjögren Syndrome: What if Sjögren was right after all? Arthritis Care & Research. PMID 28217861 DOI: 10.1002/Acr.23223 |
0.58 |
|
| 2017 |
Nocturne G, Boudaoud S, Ly B, Pascaud J, Paoletti A, Mariette X. Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas. Journal of Autoimmunity. PMID 28214146 DOI: 10.1016/J.Jaut.2017.02.001 |
0.629 |
|
| 2017 |
Sellam J, Rivière E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferracioli G, Soubrier M, Ly B, Chavez HH, Taoufik Y, Dougados M, Mariette X. Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Research & Therapy. 19: 11. PMID 28115013 DOI: 10.1186/S13075-017-1221-4 |
0.507 |
|
| 2017 |
Latourte A, Gottenberg JE, Luxembourger C, Pane I, Claudepierre P, Richette P, Lafforgue P, Combe B, Cantagrel A, Sibilia J, Flipo RM, Gaudin P, Vittecoq O, Schaeverbeke T, Dougados M, ... ... Mariette X, et al. Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry. Rheumatology (Oxford, England). PMID 28053274 DOI: 10.1093/Rheumatology/Kew476 |
0.537 |
|
| 2017 |
Nocturne G, Seror R, Mariette X. Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor? Annals of the Rheumatic Diseases. 76: e3. PMID 27742658 DOI: 10.1136/Annrheumdis-2016-210566 |
0.626 |
|
| 2017 |
Nocturne G, Ly B, Boudaoud S, Bitoun S, Paoletti A, Seror R, Nicco C, Mackay F, Vincent F, Ferlicot S, Stimmer L, Roulland S, krzysiek R, Bey SH, Batteux F, ... Mariette X, et al. P028 Treatment of BAFF transgenic mice with ANTI-TNF: monoclonal ANTI-TNF are associated with a higher risk of lymphoma than etanercept Annals of the Rheumatic Diseases. 76: 182-183. DOI: 10.1136/Annrheumdis-2018-Ewrr2018.52 |
0.606 |
|
| 2017 |
Belkhir R, Burel SL, Lambotte O, Mouterde G, Pertuiset E, Dunogeant L, Marabelle A, Leary A, Voisin A, Mariette X. OP0004 Rheumatoid arthritis occuring after immune checkpoint inhibitors Annals of the Rheumatic Diseases. 76: 51-52. DOI: 10.1136/Annrheumdis-2017-Eular.3768 |
0.355 |
|
| 2017 |
Bitoun S, Roques P, Larcher T, Nocturne G, Serguera C, Chrétien P, Serre G, Grand RL, Mariette X. FRI0081 A macaque model of rheumatoid arthritis by immunization with citrullinated peptides: lessons for the human disease Annals of the Rheumatic Diseases. 76. DOI: 10.1136/Annrheumdis-2017-Eular.2843 |
0.577 |
|
| 2017 |
Alten R, Lorenz H, Mariette X, Nüßlein H, Galeazzi M, Navarro F, Chartier M, Elbez Y, Rauch C, Bars ML. FRI0245 Abatacept retention rates and prognostic factors of retention in patients with rheumatoid arthritis: 2-year results from the real-world action study Annals of the Rheumatic Diseases. 76: 577-578. DOI: 10.1136/Annrheumdis-2017-Eular.1375 |
0.312 |
|
| 2017 |
Jong TDd, Sellam J, Agca R, Vosslamber S, Witte BI, Tsang-a-Sjoe M, Mantel E, Bijlsma JW, Voskuyl AE, Nurmohamed MT, Verweij CL, Mariette X. 07.01 A multi-parameter response prediction model for rituximab in rheumatoid arthritis Annals of the Rheumatic Diseases. DOI: 10.1136/Annrheumdis-2016-211054.1 |
0.492 |
|
| 2017 |
Vincent FB, Pavy S, Krzysiek R, Lequerré T, Sellam J, Taoufik Y, Mariette X, Miceli-Richard C. Effet des concentrations sériques résiduelles d’anti-TNF et d’anticorps anti-médicaments (ADAb) sur l’efficacité thérapeutique à court terme après switch vers un autre anti-TNF dans la polyarthrite rhumatoïde et la spondyloarthrite axiale Revue Du Rhumatisme. 84: 352-355. DOI: 10.1016/J.Rhum.2017.03.009 |
0.662 |
|
| 2017 |
Rivoisy C, Tubach F, Roy C, Nicolas N, Mariette X, Salmon D, Lortholary O, Bourgarit A. Aggravation paradoxale des tuberculoses acquises sous anti-TNF : incidence et facteurs de risque de survenue d’un IRIS Revue Du Rhumatisme. 84: 145-150. DOI: 10.1016/J.Rhum.2016.12.002 |
0.309 |
|
| 2017 |
Glanowski C, Belkhir R, Bergé E, Seror R, Tomi A, Chevalier X, Berenbaum F, Mariette X, Sellam J. Prevalence of hand osteoarthritis in a model of auto-immune disease, Sjögren syndrome: results of a prospective study Osteoarthritis and Cartilage. 25: S355. DOI: 10.1016/J.Joca.2017.02.604 |
0.463 |
|
| 2016 |
Iannone F, Courvoisier DS, Gottenberg JE, Hernandez MV, Lie E, Canhão H, Pavelka K, Hetland ML, Turesson C, Mariette X, Choquette D, Finckh A. Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA). Clinical Rheumatology. PMID 27966068 DOI: 10.1007/S10067-016-3505-5 |
0.748 |
|
| 2016 |
Sellam J, Rivière E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferraciolli G, Soubrier M, Ly B, Hendel Chavez H, Taoufik Y, Dougados M, Mariette X. Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Research & Therapy. 18: 294. PMID 27964756 DOI: 10.1186/S13075-016-1190-Z |
0.536 |
|
| 2016 |
Portier A, Gossec L, Tubach F, Alfaiate T, Pham T, Saraux A, Soubrier M, Schaeverbeke T, Maillefert JF, Mariette X, Hajage D, Fautrel B. Patient-perceived flares in rheumatoid arthritis: A sub-analysis of the STRASS treatment tapering strategy trial. Joint, Bone, Spine : Revue Du Rhumatisme. PMID 27932278 DOI: 10.1016/J.Jbspin.2016.10.001 |
0.344 |
|
| 2016 |
Brito-Zerón P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, Li X, Baldini C, Gottenberg JE, Danda D, Quartuccio L, Priori R, Hernandez-Molina G, Kruize AA, Valim V, ... ... Mariette X, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Annals of the Rheumatic Diseases. PMID 27899373 DOI: 10.1136/Annrheumdis-2016-209952 |
0.323 |
|
| 2016 |
Zhao L, Nocturne G, Haskett S, Boudaoud S, Lazure T, Le Pajolec C, Mariette X, Mingueneau M, Banerjee D. Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome. Rheumatology (Oxford, England). PMID 27803305 DOI: 10.1093/Rheumatology/Kew360 |
0.581 |
|
| 2016 |
Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome A consensus and data-driven methodology involving three international patient cohorts. Annals of the Rheumatic Diseases. PMID 27789466 DOI: 10.1136/Annrheumdis-2016-210571 |
0.312 |
|
| 2016 |
Cui J, Diogo D, Stahl EA, Canhao H, Mariette X, Greenberg JD, Okada Y, Pappas DA, Fulton RS, Tak PP, Nurmohamed MT, Lee A, Larson DE, Kurreeman F, Deluca TL, et al. The role of rare protein-coding variants to anti-TNF treatment response in rheumatoid arthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27788309 DOI: 10.1002/Art.39966 |
0.595 |
|
| 2016 |
Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27785888 DOI: 10.1002/Art.39859 |
0.312 |
|
| 2016 |
Gottenberg JE, Brocq O, Perdriger A, Lassoued S, Berthelot JM, Wendling D, Euller-Ziegler L, Soubrier M, Richez C, Fautrel B, Constantin AL, Mariette X, Morel J, Gilson M, Cormier G, et al. Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial. Jama. 316: 1172-1180. PMID 27654603 DOI: 10.1001/Jama.2016.13512 |
0.54 |
|
| 2016 |
Courvoisier DS, Alpizar-Rodriguez D, Gottenberg JE, Hernandez MV, Iannone F, Lie E, Santos MJ, Pavelka K, Turesson C, Mariette X, Choquette D, Hetland ML, Finckh A. Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study. Ebiomedicine. PMID 27558858 DOI: 10.1016/J.Ebiom.2016.08.024 |
0.331 |
|
| 2016 |
Sieberts SK, Zhu F, García-García J, Stahl E, Pratap A, Pandey G, Pappas D, Aguilar D, Anton B, Bonet J, Eksi R, Fornés O, Guney E, Li H, Marín MA, ... ... Mariette X, et al. Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nature Communications. 7: 12460. PMID 27549343 DOI: 10.1038/Ncomms12460 |
0.317 |
|
| 2016 |
Emery P, Bingham CO, Burmester GR, Bykerk VP, Furst DE, Mariette X, Heijde DV, Vollenhoven RV, Arendt C, Mountian I, Purcaru O, Tatla D, VanLunen B, Weinblatt ME. Response to: 'Let's stop fooling ourselves. In RA, only ACR/EULAR criteria define remission and equate with absence of disease!' by Boers. Annals of the Rheumatic Diseases. PMID 27519773 DOI: 10.1136/Annrheumdis-2016-210083 |
0.311 |
|
| 2016 |
Nocturne G, Cornec D, Seror R, Mariette X. Use of Biologics in Sjögren's Syndrome. Rheumatic Diseases Clinics of North America. 42: 407-17. PMID 27431344 DOI: 10.1016/J.Rdc.2016.03.001 |
0.619 |
|
| 2016 |
Sigaux J, Hamze M, Daien C, Morel J, Krzysiek R, Pallardy M, Maillere B, Mariette X, Miceli-Richard C. Immunogenicity of tocilizumab in patients with rheumatoid arthritis. Joint, Bone, Spine : Revue Du Rhumatisme. PMID 27369643 DOI: 10.1016/J.Jbspin.2016.04.013 |
0.595 |
|
| 2016 |
Mercer LK, Askling J, Raaschou P, Dixon WG, Dreyer L, Hetland ML, Strangfeld A, Zink A, Mariette X, Finckh A, Canhao H, Iannone F, Zavada J, Morel J, Gottenberg JE, et al. Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers. Annals of the Rheumatic Diseases. PMID 27307502 DOI: 10.1136/Annrheumdis-2016-209285 |
0.352 |
|
| 2016 |
Desbois AC, Addimanda O, Bertrand A, Deroux A, Pérard L, Depaz R, Hachulla E, Lambert M, Launay D, Subran B, Ackerman F, Mariette X, Cohen F, Marie I, Salvarini C, et al. Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study. Medicine. 95: e3550. PMID 27281066 DOI: 10.1097/Md.0000000000003550 |
0.352 |
|
| 2016 |
Emery P, Bingham CO, Burmester GR, Bykerk VP, Furst DE, Mariette X, van der Heijde D, van Vollenhoven R, Arendt C, Mountian I, Purcaru O, Tatla D, VanLunen B, Weinblatt ME. Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study. Annals of the Rheumatic Diseases. PMID 27165179 DOI: 10.1136/Annrheumdis-2015-209057 |
0.326 |
|
| 2016 |
Carvajal Alegria G, Guellec D, Mariette X, Gottenberg JE, Dernis E, Dubost JJ, Trouvin AP, Hachulla E, Larroche C, Le Guern V, Cornec D, Devauchelle-Pensec V, Saraux A. Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort. Rmd Open. 2: e000179. PMID 27110384 DOI: 10.1136/Rmdopen-2015-000179 |
0.343 |
|
| 2016 |
Harris VM, Sharma R, Cavett J, Kurien BT, Liu K, Koelsch KA, Rasmussen A, Radfar L, Lewis D, Stone DU, Kaufman CE, Li S, Segal B, Wallace DJ, Weisman MH, ... ... Mariette X, et al. Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome. Clinical Immunology (Orlando, Fla.). PMID 27109640 DOI: 10.1016/J.Clim.2016.04.002 |
0.576 |
|
| 2016 |
Vincent FB, Pavy S, Krzysiek R, Lequerré T, Sellam J, Taoufik Y, Mariette X, Miceli-Richard C. Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis. Joint, Bone, Spine : Revue Du Rhumatisme. PMID 27066773 DOI: 10.1016/J.Jbspin.2015.07.015 |
0.662 |
|
| 2016 |
Mingueneau M, Boudaoud S, Haskett S, Reynolds TL, Nocturne G, Norton E, Zhang X, Constant M, Park D, Wang W, Lazure T, Le Pajolec C, Ergun A, Mariette X. Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation. The Journal of Allergy and Clinical Immunology. PMID 27045581 DOI: 10.1016/J.Jaci.2016.01.024 |
0.618 |
|
| 2016 |
Cheung PP, Mari K, Devauchelle-Pensec V, Jousse-Joulin S, D'Agostino MA, Chalès G, Gaudin P, Mariette X, Saraux A, Dougados M. Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis. Rmd Open. 2: e000205. PMID 27042336 DOI: 10.1136/Rmdopen-2015-000205 |
0.307 |
|
| 2016 |
Danion F, Rosine N, Belkhir R, Gottenberg JE, Hachulla E, Chatelus E, Pugnet G, Pers YM, Mariette X, Sibilia J, Seror R. Efficacy of abatacept in systemic lupus erythematosus: a retrospective analysis of 11 patients with refractory disease. Lupus. 25: 1440-1447. PMID 27013663 DOI: 10.1177/0961203316640911 |
0.345 |
|
| 2016 |
Lahaye C, Soubrier M, Mulliez A, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Mariette X, Gottenberg JE. Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology's ORA registry. Rheumatology (Oxford, England). 55: 874-82. PMID 26822072 DOI: 10.1093/Rheumatology/Kev437 |
0.311 |
|
| 2016 |
Gottenberg JE, Courvoisier DS, Hernandez MV, Iannone F, Lie E, Canhão H, Pavelka K, Hetland ML, Turesson C, Mariette X, Finckh A. Rheumatoid factor and anti-citrullinated protein antibody positivity are associated with a better effectiveness of abatacept: Results from the Pan-European registry analysis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26815727 DOI: 10.1002/Art.39595 |
0.327 |
|
| 2016 |
Seror R, Boudaoud S, Pavy S, Nocturne G, Schaeverbeke T, Saraux A, Chanson P, Gottenberg JE, Devauchelle-Pensec V, Tobón GJ, Mariette X, Miceli-Richard C. Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort. Scientific Reports. 6: 18421. PMID 26785768 DOI: 10.1038/Srep18421 |
0.713 |
|
| 2016 |
Nocturne G, Seror R, Mariette X. Reply. Arthritis & Rheumatology (Hoboken, N.J.). 68: 1319-20. PMID 26749273 DOI: 10.1002/Art.39584 |
0.522 |
|
| 2016 |
Rivière E, Ly B, Boudaoud S, Chavez H, Nocturne G, Chanson P, Miceli Richard C, Mariette X. Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sjögren syndrome: comparison of different kits. Annals of the Rheumatic Diseases. 75: 633-5. PMID 26659716 DOI: 10.1136/Annrheumdis-2015-208557 |
0.591 |
|
| 2016 |
Tomi AL, Belkhir R, Nocturne G, Desmoulins F, Berge E, Pavy S, Miceli-Richard C, Mariette X, Seror R. Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients With Primary Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). 68: 1245-50. PMID 26636425 DOI: 10.1002/Art.39534 |
0.727 |
|
| 2016 |
Nocturne G, Seror R, Fogel O, Belkhir R, Boudaoud S, Saraux A, Larroche C, Le Guern V, Gottenberg JE, Mariette X. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). 67: 3226-33. PMID 26359802 DOI: 10.1002/Art.39315 |
0.637 |
|
| 2016 |
Miceli-Richard C, Wang-Renault SF, Boudaoud S, Busato F, Lallemand C, Bethune K, Belkhir R, Nocturne G, Mariette X, Tost J. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 75: 933-40. PMID 26183421 DOI: 10.1136/Annrheumdis-2014-206998 |
0.697 |
|
| 2016 |
Fautrel B, Pham T, Alfaiate T, Gandjbakhch F, Foltz V, Morel J, Dernis E, Gaudin P, Brocq O, Solau-Gervais E, Berthelot JM, Balblanc JC, Mariette X, Tubach F. Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study). Annals of the Rheumatic Diseases. 75: 59-67. PMID 26103979 DOI: 10.1136/Annrheumdis-2014-206696 |
0.325 |
|
| 2016 |
Salmon JH, Gottenberg JE, Ravaud P, Cantagrel A, Combe B, Flipo RM, Schaeverbeke T, Houvenagel E, Gaudin P, Loeuille D, Rist S, Dougados M, Sibilia J, Le Loët X, Meyer O, ... ... Mariette X, et al. Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry. Annals of the Rheumatic Diseases. 75: 1108-1113. PMID 26048170 DOI: 10.1136/Annrheumdis-2015-207362 |
0.325 |
|
| 2016 |
Fogel O, Rivière E, Seror R, Nocturne G, Ly B, Boudaoud S, Gottenberg J, Dubost J, Le Guern V, Dieudé P, Chanson P, Nititham J, Taylor K, Criswell L, Mariette X, et al. AB0150 Understanding The Role of The IL12/iL35 Balance in Sjögren Syndrome Annals of the Rheumatic Diseases. 75: 948.1-948. DOI: 10.1136/Annrheumdis-2016-Eular.5756 |
0.668 |
|
| 2016 |
Nocturne G, Ly B, Boudaoud S, Seror R, Zitvogel L, Mariette X. FRI0179 anti-TNF Therapy Is Associated with An Impaired Function of Nk Cells and A Defective Immunosurveillance against B-Cell Lymphomas Annals of the Rheumatic Diseases. 75: 494.2-495. DOI: 10.1136/Annrheumdis-2016-Eular.4140 |
0.637 |
|
| 2016 |
Sellam J, Rivière E, Courties A, Rouzaire P, Tolusso B, Vital E, Emery P, Ferraciolli G, Soubrier M, Dougados M, Mariette X. SAT0171 Serum IL-33 Independently Predicts Response To Rituximab in Rheumatoid Arthritis: Data from The Smart and Replication Cohorts Annals of the Rheumatic Diseases. 75: 729.1-729. DOI: 10.1136/Annrheumdis-2016-Eular.3869 |
0.548 |
|
| 2016 |
Morel J, Constantin A, Dernis E, Rist S, Flipo RM, Schaeverbeke T, Vittecoq O, Soubrier M, Saraux A, Combe B, Dougados M, Pinta A, Baron G, Gottenberg J-, Mariette X, et al. FRI0219 Risk Factors of Severe Infections in Patients with Rheumatoid Arthritis Treated with Tocilizumab in The French Registry Regate (Registry –Roactemra) Annals of the Rheumatic Diseases. 75: 511-511. DOI: 10.1136/Annrheumdis-2016-Eular.3249 |
0.306 |
|
| 2016 |
Alten R, Nüßlein H, Galeazzi M, Lorenz H, Mariette X, Cantagrel A, Chartier M, Elbez Y, Rauch C, Le Bars M. AB0371 Is Switching from IV To SC Abatacept Therapy Sustainable in The Real World? 1-Year Analysis of The Prospective, International Action Study Annals of the Rheumatic Diseases. 75: 1030.3-1031. DOI: 10.1136/Annrheumdis-2016-Eular.1515 |
0.323 |
|
| 2016 |
Mariette X, Bingham C, Burmester G, Bykerk V, Emery P, Furst D, van der Heijde D, van Vollenhoven R, VanLunen B, Arendt C, Weinblatt M. THU0163 Early Response as A Predictor of Long-Term Clinical Response in DMARD-Naïve Patients with Severe, Active and Progressive RA Treated with Certolizumab Pegol plus Optimized MTX versus Optimized MTX Alone Annals of the Rheumatic Diseases. 75: 242.1-242. DOI: 10.1136/Annrheumdis-2016-Eular.1471 |
0.32 |
|
| 2016 |
Alten R, Nüßlein H, Galeazzi M, Lorenz H, Mariette X, Cantagrel A, Chartier M, Elbez Y, Rauch C, Le Bars M. THU0066 Do Predictors of IV Abatacept Retention Depend on The Line of Rheumatoid Arthritis Treatment: 12-Month Interim Analysis of The Observational, Prospective Action Study Annals of the Rheumatic Diseases. 75: 202.1-202. DOI: 10.1136/Annrheumdis-2016-Eular.1289 |
0.314 |
|
| 2016 |
Rivière E, Ly B, Boudaoud S, Chavez H, Nocturne G, Chanson P, Richard CM, Mariette X. Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sjögren syndrome: Comparison of different kits Annals of the Rheumatic Diseases. 75: 633-635. DOI: 10.1136/annrheumdis-2015-208557 |
0.568 |
|
| 2016 |
Nocturne G, Tahmasebi F, Boudaoud S, Ly B, Mariette X. Le tofacitinib impacte négativement la fonction des NK et leur activité anti-lymphomateuse Revue Du Rhumatisme. 83: A275-A276. DOI: 10.1016/S1169-8330(16)30645-7 |
0.538 |
|
| 2016 |
Nocturne G, Ly B, Boudaoud S, Seror R, Zitvogel L, Mariette X. Le traitement par anti-TNF impacte négativement la fonction des NK et leur activité anti-lymphomateuse Revue Du Rhumatisme. 83: A274. DOI: 10.1016/S1169-8330(16)30641-X |
0.551 |
|
| 2016 |
Nocturne G, Ly B, Boudaoud S, Seror R, Nicco C, Chereau C, Kavian N, Batteux F, Mackay F, Vincent F, Lazure T, Krzysiek R, Hacein-Bey S, Stimmer L, Ferlicot S, ... Mariette X, et al. Les souris BAFF transgéniques traitées par anti-TNF ont une augmentation du risque de lymphome sous anticorps monoclonaux et pas sous récepteur soluble Revue Du Rhumatisme. 83: A235-A236. DOI: 10.1016/S1169-8330(16)30563-4 |
0.592 |
|
| 2016 |
Mariette X, Alten R, Nüßlein H, Galeazzi M, Lorenz H, Cantagrel A, Chartier M, Chelbani L, Heitzmann J, Rauch C, Le Bars M. Caractéristiques à l’inclusion et maintien d’abatacept chez les patients français présentant une Polyarthrite Rhumatoïde comparés aux patients des autres pays : analyse intermédiaire à 12 mois de l’étude internationale prospective en vie réelle ACTION Revue Du Rhumatisme. 83: A172-A173. DOI: 10.1016/S1169-8330(16)30439-2 |
0.318 |
|
| 2016 |
Glanowski C, Sellam J, Bergé E, Seror R, Tomi A, Chevalier X, Berenbaum F, Mariette X, Belkhir R. Prévalence de l’arthrose digitale dans le syndrome de Sjögren : résultats d’une étude prospective Revue Du Rhumatisme. 83: A55. DOI: 10.1016/S1169-8330(16)30236-8 |
0.537 |
|
| 2016 |
Kleinmann J, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacré K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, ... ... Mariette X, et al. Recommandations francophones, internationales et multidisciplinaires d’experts pour l’utilisation de biomédicaments dans le lupus érythémateux systémique : le groupe de travail du CRI-IMIDIATE La Revue De MéDecine Interne. 37: A80-A81. DOI: 10.1016/J.Revmed.2016.10.039 |
0.503 |
|
| 2015 |
Nocturne G, Cornec D, Seror R, Mariette X. New biological therapies in Sjögren's syndrome. Best Practice & Research. Clinical Rheumatology. 29: 783-93. PMID 27107513 DOI: 10.1016/J.Berh.2016.02.009 |
0.624 |
|
| 2015 |
Liu K, Kurien BT, Zimmerman SL, Kaufman KM, Taft DH, Kottyan LC, Lazaro S, Weaver CA, Ice JA, Adler AJ, Chodosh J, Radfar L, Rasmussen A, Stone DU, Lewis DM, ... ... Mariette X, et al. X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26713507 DOI: 10.1002/Art.39560 |
0.788 |
|
| 2015 |
Brito-Zerón P, Theander E, Baldini C, Seror R, Retamozo S, Quartuccio L, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Bombardieri S, de Vita S, Mandl T, Ng WF, et al. Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations. Expert Review of Clinical Immunology. 1-20. PMID 26691952 DOI: 10.1586/1744666X.2016.1109449 |
0.346 |
|
| 2015 |
Nocturne G, Virone A, Ng WF, Le Guern V, Hachulla E, Cornec D, Daien C, Vittecoq O, Bienvenu B, Marcelli C, Wendling D, Amoura Z, Dhote R, Lavigne C, Fior R, ... ... Mariette X, et al. Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sjögren's Syndrome. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26606524 DOI: 10.1002/Art.39518 |
0.639 |
|
| 2015 |
Emery P, Bingham C, Burmester G, Bykerk V, Furst D, Mariette X, Purcaru O, Coteur G, Vanlunen B, Weinblatt M. Improvements in Patient-Reported outcomes Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis: Results from the C-Early Randomized, Double-Blind, Controlled Phase 3 Study. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: A707-8. PMID 26533965 DOI: 10.1016/J.Jval.2015.09.2671 |
0.317 |
|
| 2015 |
Payet J, Belkhir R, Gottenberg JE, Bergé E, Desmoulins F, Meyer O, Mariette X, Seror R. ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome? Rmd Open. 1: e000066. PMID 26509066 DOI: 10.1136/Rmdopen-2015-000066 |
0.373 |
|
| 2015 |
Finckh A, Neto D, Iannone F, Loza E, Lie E, van Riel P, Hetland ML, Pavelka K, Gottenberg JE, Canhão H, Mariette X, Turesson C. The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries. Rmd Open. 1: e000040. PMID 26509062 DOI: 10.1136/Rmdopen-2014-000040 |
0.339 |
|
| 2015 |
Salmon JH, Cacoub P, Combe B, Sibilia J, Pallot-Prades B, Fain O, Cantagrel A, Dougados M, Andres E, Meyer O, Carli P, Pertuiset E, Pane I, Maurier F, Ravaud P, ... Mariette X, et al. Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry. Rmd Open. 1: e000034. PMID 26509060 DOI: 10.1136/Rmdopen-2014-000034 |
0.346 |
|
| 2015 |
Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, et al. EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide. Rmd Open. 1: e000022. PMID 26509054 DOI: 10.1136/Rmdopen-2014-000022 |
0.314 |
|
| 2015 |
Devauchelle-Pensec V, Gottenberg JE, Jousse-Joulin S, Berthelot JM, Perdriger A, Hachulla E, Hatron PY, Puechal X, Le Guern V, Sibilia J, Chiche L, Goeb V, Vittecoq O, Larroche C, Fauchais AL, ... ... Mariette X, et al. Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome? Plos One. 10: e0133907. PMID 26368934 DOI: 10.1371/Journal.Pone.0133907 |
0.309 |
|
| 2015 |
Nocturne G, Tarn J, Boudaoud S, Locke J, Miceli-Richard C, Hachulla E, Dubost JJ, Bowman S, Gottenberg JE, Criswell LA, Lessard CJ, Sivils KL, Carapito R, Bahram S, Seror R, ... ... Mariette X, et al. Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphoma. Annals of the Rheumatic Diseases. PMID 26338037 DOI: 10.1136/Annrheumdis-2015-207731 |
0.715 |
|
| 2015 |
Seror R, Nocturne G, Lazure T, Hendel-Chavez H, Desmoulins F, Belkhir R, Ravaud P, Benbijja M, Poirier-Colame V, Taoufik Y, Mariette X. Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study. Arthritis Research & Therapy. 17: 241. PMID 26336930 DOI: 10.1186/S13075-015-0750-Y |
0.622 |
|
| 2015 |
Terrier B, Marie I, Lacraz A, Belenotti P, Bonnet F, Chiche L, Graffin B, Hot A, Kahn JE, Michel C, Quemeneur T, de Saint-Martin L, Hermine O, Léger JM, Mariette X, et al. Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature. Journal of Autoimmunity. PMID 26320984 DOI: 10.1016/J.Jaut.2015.08.008 |
0.302 |
|
| 2015 |
Nocturne G, Pavy S, Boudaoud S, Seror R, Goupille P, Chanson P, van der Heijde D, van Gaalen F, Berenbaum F, Mariette X, Briot K, Feydy A, Claudepierre P, Dieudé P, Nithitham J, et al. Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort. Plos One. 10: e0134974. PMID 26313358 DOI: 10.1371/Journal.Pone.0134974 |
0.692 |
|
| 2015 |
Zaidan M, Terrier B, Pozdzik A, Frouget T, Rioux-Leclercq N, Combe C, Lepreux S, Hummel A, Noël LH, Marie I, Legallicier B, François A, Huart A, Launay D, Kaplanski G, ... ... Mariette X, et al. Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN. Journal of the American Society of Nephrology : Jasn. PMID 26260165 DOI: 10.1681/Asn.2015020114 |
0.309 |
|
| 2015 |
De Vita S, Quartuccio L, Seror R, Salvin S, Ravaud P, Fabris M, Nocturne G, Gandolfo S, Isola M, Mariette X. Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study. Rheumatology (Oxford, England). 54: 2249-56. PMID 26242856 DOI: 10.1093/Rheumatology/Kev257 |
0.584 |
|
| 2015 |
Danlos FX, Daoued F, Seror R, Mariette X. Orbital Myositis and Primary Sjögren Syndrome. The Journal of Rheumatology. 42: 1536-7. PMID 26233955 DOI: 10.3899/Jrheum.141318 |
0.362 |
|
| 2015 |
Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, ... ... Mariette X, et al. Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients. Journal of Autoimmunity. PMID 26162757 DOI: 10.1016/J.Jaut.2015.06.005 |
0.336 |
|
| 2015 |
Gossec L, Danré A, Combe B, Le Loët X, Tebib J, Sibilia J, Mariette X, Dougados M. Improvement in patient-reported outcomes after rituximab in rheumatoid arthritis patients: An open-label assessment of 175 patients. Joint, Bone, Spine : Revue Du Rhumatisme. 82: 451-4. PMID 26162632 DOI: 10.1016/J.Jbspin.2015.02.007 |
0.322 |
|
| 2015 |
Jallouli M, Galicier L, Zahr N, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Pourrat J, ... ... Mariette X, et al. Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). 67: 2176-84. PMID 25989906 DOI: 10.1002/Art.39194 |
0.482 |
|
| 2015 |
Noel N, Dutasta F, Costedoat-Chalumeau N, Bienvenu B, Mariette X, Geffray L, Sene D, Chaidi RB, Michot JM, Fain O, Darnige L, Ankri A, Cacoub P, Piette JC, Saadoun D. Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndrome Autoimmunity Reviews. 14: 680-685. PMID 25864630 DOI: 10.1016/J.Autrev.2015.03.007 |
0.307 |
|
| 2015 |
Diogo D, Bastarache L, Liao KP, Graham RR, Fulton RS, Greenberg JD, Eyre S, Bowes J, Cui J, Lee A, Pappas DA, Kremer JM, Barton A, Coenen MJ, Franke B, ... ... Mariette X, et al. TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits. Plos One. 10: e0122271. PMID 25849893 DOI: 10.1371/Journal.Pone.0122271 |
0.328 |
|
| 2015 |
Miceli-Richard C, Taylor KE, Nititham J, Seror R, Nocturne G, Boudaoud S, Dieude P, Constantin A, Devauchelle-Pensec V, Tobón GJ, Mariette X, Criswell LA. Genetic contribution of DKK-1 polymorphisms to RA structural severity and DKK-1 level of expression. Annals of the Rheumatic Diseases. 74: 1480-1. PMID 25805736 DOI: 10.1136/Annrheumdis-2014-206530 |
0.717 |
|
| 2015 |
Seror R, Le Gall-David S, Bonnaure-Mallet M, Schaeverbeke T, Cantagrel A, Minet J, Gottenberg JE, Chanson P, Ravaud P, Mariette X. Association of Anti-Porphyromonas gingivalis Antibody Titers With Nonsmoking Status in Early Rheumatoid Arthritis: Results From the Prospective French Cohort of Patients With Early Rheumatoid Arthritis. Arthritis & Rheumatology (Hoboken, N.J.). 67: 1729-37. PMID 25779552 DOI: 10.1002/Art.39118 |
0.332 |
|
| 2015 |
Nocturne G, Mariette X. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. British Journal of Haematology. 168: 317-27. PMID 25316606 DOI: 10.1111/Bjh.13192 |
0.635 |
|
| 2015 |
Kottyan LC, Zoller EE, Bene J, Lu X, Kelly JA, Rupert AM, Lessard CJ, Vaughn SE, Marion M, Weirauch MT, Namjou B, Adler A, Rasmussen A, Glenn S, Montgomery CG, ... ... Mariette X, et al. The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Human Molecular Genetics. 24: 582-96. PMID 25205108 DOI: 10.1093/Hmg/Ddu455 |
0.585 |
|
| 2015 |
Dougados M, Soubrier M, Perrodeau E, Gossec L, Fayet F, Gilson M, Cerato MH, Pouplin S, Flipo RM, Chabrefy L, Mouterde G, Euller-Ziegler L, Schaeverbeke T, Fautrel B, Saraux A, ... ... Mariette X, et al. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Annals of the Rheumatic Diseases. 74: 1725-33. PMID 24872377 DOI: 10.1136/Annrheumdis-2013-204733 |
0.311 |
|
| 2015 |
Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Dörner T, Bootsma H, Tzioufas A, Solans-Laqué R, Mandl T, Gottenberg JE, Hachulla E, Sivils KL, Ng WF, Fauchais AL, ... ... Mariette X, et al. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Annals of the Rheumatic Diseases. 74: 859-66. PMID 24442883 DOI: 10.1136/Annrheumdis-2013-204615 |
0.362 |
|
| 2015 |
Mariette X, Seror R, Quartuccio L, Baron G, Salvin S, Fabris M, Desmoulins F, Nocturne G, Ravaud P, De Vita S. Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study. Annals of the Rheumatic Diseases. 74: 526-31. PMID 24347569 DOI: 10.1136/Annrheumdis-2013-203991 |
0.622 |
|
| 2015 |
Nocturne G, Virone A, Le Guern V, Hachulla E, Daien C, Cornec D, Vittecoq O, Boris B, Marcelli C, Lavigne C, Wendling D, Amoura Z, Dhote R, Gottenberg J, Seror R, ... Mariette X, et al. SAT0399 Chronic Antigenic Stimulation and Activity of the Disease Are Predictive of Lymphoma Development in Primary SjÖgren Syndrome: A Case Control Study of 64 Cases Annals of the Rheumatic Diseases. 74: 803.2-804. DOI: 10.1136/annrheumdis-2015-eular.6116 |
0.548 |
|
| 2015 |
Sigaux J, Hamze M, Daien C, Morel J, Krzysiek R, Pallardy M, Maillere B, Mariette X, Miceli-Richard C. AB0462 The Lack of Antidrug Antibodies Among Patients Treated with Tocilizumab: A Clue to Good Efficacy Profiles When Used as Monotherapy? Annals of the Rheumatic Diseases. 74: 1050.2-1050. DOI: 10.1136/Annrheumdis-2015-Eular.6038 |
0.571 |
|
| 2015 |
Nocturne G, Seror R, Fogel O, Dieudé P, Dubost J, Fauchais A, Goëb V, Hachulla E, Larroche C, Le Guern V, Morel J, Perdriger A, Puechal X, Rist S, Devauchelle-Pensec V, ... ... Mariette X, et al. OP0080 CXCL13 and CCL11 Serum Levels are Associated With Lymphoma Occurrence and Disease Activity in Primary Sjögren Syndrome: Data from the French Prospective Cohort Assessment Annals of the Rheumatic Diseases. 74: 99.1-99. DOI: 10.1136/Annrheumdis-2015-Eular.5149 |
0.599 |
|
| 2015 |
Brito Zeron P, Kostov B, Seror R, Baldini C, Quartuccio L, Kvarnstrom M, Kruize A, Hernández Molina G, Praprotnik S, Bartoloni E, Solans R, Theander E, Valim V, Priori R, Zeher M, ... ... Mariette X, et al. FRI0419 Big Data Sjogren Project (Eular-SS Task Force International Network): Systemic Involvement at Diagnosis Evaluated by the Essdai in 3314 Patients with Primary Sjögren Syndrome Annals of the Rheumatic Diseases. 74: 578.2-578. DOI: 10.1136/Annrheumdis-2015-Eular.4752 |
0.328 |
|
| 2015 |
Gottenberg J, Seror R, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost J, Fauchais A, Goeb V, Hachulla E, Hatron P, Larroche C, Le Guern V, Micelli-Richard C, Morel J, Perdriger A, ... ... Mariette X, et al. SAT0379 Is Fatigue Immune-Mediated in Primary SjÖgren's Syndrome? Data from the Prospective Assess Cohort Annals of the Rheumatic Diseases. 74: 796.2-796. DOI: 10.1136/annrheumdis-2015-eular.3949 |
0.554 |
|
| 2015 |
Rivière E, Arnaud L, Ebbo M, Allanore Y, Claudepierre P, Dernis E, Ziza J, Philippe P, Richez C, Soubrier M, Miceli-Richard C, Mariette X, Pavy S. SAT0244 Association Between Spondyloarthritis and Takayasu Arteritis: a Study of 14 Cases Annals of the Rheumatic Diseases. 74: 747.1-747. DOI: 10.1136/Annrheumdis-2015-Eular.3570 |
0.573 |
|
| 2015 |
Vita SD, Quartuccio L, Seror R, Salvin S, Ravaud P, Fabris M, Nocturne G, Gandolfo S, Isola M, Mariette X. THU0392 Efficacy and Safety of Belimumab Given for 12 Months in Primary sjögren's Syndrome: The Beliss Open-Label Phase II Study Annals of the Rheumatic Diseases. 74: 338-339. DOI: 10.1136/Annrheumdis-2015-Eular.3101 |
0.618 |
|
| 2015 |
Emery P, Bingham C, Burmester G, Bykerk V, Furst D, Mariette X, Purcaru O, Coteur G, VanLunen B, Weinblatt M. SAT0165 Improvements in Patient-Reported Outcomes and Workplace and Household Productivity Following 52 Weeks of Treatment with Certolizumab Pegol in Combination with Methotrexate in Dmard-Naïve Early Rheumatoid Arthritis Patients: Results from the C-Early Randomized, Double-Blind, Controlled Phase 3 Study Annals of the Rheumatic Diseases. 74: 712.2-713. DOI: 10.1136/Annrheumdis-2015-Eular.1499 |
0.313 |
|
| 2015 |
Emery P, Bingham C, Burmester G, Bykerk V, Furst D, Mariette X, van der Heijde D, Tatla D, Arendt C, Mountian I, VanLunen B, Weinblatt M. SAT0164 The First Study of Certolizumab Pegol in Combination with Methotrexate in Dmard-Naïve Early Rheumatoid Arthritis Patients Led to Sustained Clinical Response and Inhibition of Radiographic Progression at 52 Weeks: The C-Early Randomized, Double-Blind, Controlled Phase 3 Study Annals of the Rheumatic Diseases. 74: 712.1-712. DOI: 10.1136/Annrheumdis-2015-Eular.1493 |
0.311 |
|
| 2015 |
Mercer L, Askling J, Raaschou P, Dixon W, Dreyer L, Hetland M, Mellemkjær L, Strangfeld A, Zink A, Iannone F, Finckh A, Zavada J, Canhao H, Martins F, Mariette X, et al. 099. Risk of Developing a First Invasive Melanoma in Rheumatoid Arthritis Patients Treated with Biologics: Results of a Collaborative Project of 11 European Biologics Registers Rheumatology. 54. DOI: 10.1093/Rheumatology/Kev088.099 |
0.302 |
|
| 2015 |
Jallouli M, Galicier L, Zahr N, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Pourrat J, ... ... Mariette X, et al. Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus Arthritis and Rheumatology. 67: 2176-2184. DOI: 10.1002/art.39194 |
0.417 |
|
| 2014 |
Durez P, Vandepapeliere P, Miranda P, Toncheva A, Berman A, Kehler T, Mociran E, Fautrel B, Mariette X, Dhellin O, Fanget B, Ouary S, Grouard-Vogel G, Boissier MC. Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial. Plos One. 9: e113465. PMID 25517733 DOI: 10.1371/Journal.Pone.0113465 |
0.304 |
|
| 2014 |
Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dörner T, Tzioufas A, Gottenberg JE, Solans Laqué R, ... ... Mariette X, et al. Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Annals of the Rheumatic Diseases. PMID 25480887 DOI: 10.1136/Annrheumdis-2014-206008 |
0.361 |
|
| 2014 |
Gottenberg JE, Ravaud P, Puéchal X, Le Guern V, Sibilia J, Goeb V, Larroche C, Dubost JJ, Rist S, Saraux A, Devauchelle-Pensec V, Morel J, Hayem G, Hatron P, Perdriger A, ... ... Mariette X, et al. Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial. Jama. 312: 249-58. PMID 25027140 DOI: 10.1001/Jama.2014.7682 |
0.32 |
|
| 2014 |
Couderc M, Gottenberg JE, Mariette X, Pereira B, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Soubrier M. Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry. Rheumatology (Oxford, England). 53: 1788-93. PMID 24821852 DOI: 10.1093/Rheumatology/Keu176 |
0.317 |
|
| 2014 |
Sellam J, Marion-Thore S, Dumont F, Jacques S, Garchon HJ, Rouanet S, Taoufik Y, Hendel-Chavez H, Sibilia J, Tebib J, Le Loët X, Combe B, Dougados M, Mariette X, Chiocchia G. Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial. Arthritis & Rheumatology (Hoboken, N.J.). 66: 2015-25. PMID 24756903 DOI: 10.1002/Art.38671 |
0.537 |
|
| 2014 |
Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, et al. Treatment of primary Sjögren syndrome with rituximab: a randomized trial. Annals of Internal Medicine. 160: 233-42. PMID 24727841 DOI: 10.7326/M13-1085 |
0.308 |
|
| 2014 |
Frazier-Mironer A, Dougados M, Mariette X, Cantagrel A, Deschamps V, Flipo RM, Logeart I, Schaeverbeke T, Sibilia J, Le Loët X, Combe B. Retention rates of adalimumab, etanercept and infliximab as first and second-line biotherapy in patients with rheumatoid arthritis in daily practice. Joint, Bone, Spine : Revue Du Rhumatisme. 81: 352-9. PMID 24721422 DOI: 10.1016/J.Jbspin.2014.02.014 |
0.303 |
|
| 2014 |
Guillaume-Czitrom S, Bachelez H, Berthelot J, Bouhnik Y, Bruckert E, Claudepierre P, Constantin A, Bandt Md, Fautrel B, Gaudin P, Goëb V, Gossec L, Gottenberg J, Goupille P, Hachulla E, ... ... Mariette X, et al. Biologic targeted therapies in pediatric rheumatology. Joint Bone Spine. 81: 2-48. PMID 24661916 DOI: 10.1016/S1297-319X(14)70020-X |
0.46 |
|
| 2014 |
Okada Y, Diogo D, Greenberg JD, Mouassess F, Achkar WA, Fulton RS, Denny JC, Gupta N, Mirel D, Gabriel S, Li G, Kremer JM, Pappas DA, Carroll RJ, Eyler AE, ... ... Mariette X, et al. Integration of sequence data from a Consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene. Plos One. 9: e87645. PMID 24520335 DOI: 10.1371/Journal.Pone.0087645 |
0.57 |
|
| 2014 |
Burmester GR, Matucci-Cerinic M, Mariette X, Navarro-Blasco F, Kary S, Unnebrink K, Kupper H. Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study. Arthritis Research & Therapy. 16: R24. PMID 24460746 DOI: 10.1186/Ar4452 |
0.343 |
|
| 2014 |
Terrier B, Marie I, Launay D, Lacraz A, Belenotti P, de Saint-Martin L, Quemeneur T, Huart A, Bonnet F, Le Guenno G, Kahn JE, Hinschberger O, Rullier P, Diot E, Lazaro E, ... ... Mariette X, et al. Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey. Autoimmunity Reviews. 13: 630-4. PMID 24418300 DOI: 10.1016/J.Autrev.2013.11.006 |
0.312 |
|
| 2014 |
Seror R, Theander E, Bootsma H, Bowman SJ, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dörner T, Ravaud P, Mariette X, Vitali C. Outcome measures for primary Sjögren's syndrome: a comprehensive review. Journal of Autoimmunity. 51: 51-6. PMID 24411404 DOI: 10.1016/J.Jaut.2013.12.010 |
0.348 |
|
| 2014 |
Gong YZ, Nititham J, Taylor K, Miceli-Richard C, Sordet C, Wachsmann D, Bahram S, Georgel P, Criswell LA, Sibilia J, Mariette X, Alsaleh G, Gottenberg JE. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome. Journal of Autoimmunity. 51: 57-66. PMID 24411167 DOI: 10.1016/J.Jaut.2013.11.003 |
0.587 |
|
| 2014 |
Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, Graham RR, Manoharan A, Ortmann W, Bhangale T, Denny JC, ... ... Mariette X, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 506: 376-81. PMID 24390342 DOI: 10.1038/Nature12873 |
0.569 |
|
| 2014 |
Roescher N, Vosters JL, Alsaleh G, Dreyfus P, Jacques S, Chiocchia G, Sibilia J, Tak PP, Chiorini JA, Mariette X, Gottenberg JE. Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjögren's syndrome as a proof of concept. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 821-7. PMID 24304965 DOI: 10.1038/Mt.2013.275 |
0.345 |
|
| 2014 |
Belkhir R, Gestermann N, Koutero M, Seror R, Tost J, Mariette X, Miceli-Richard C. Upregulation of membrane-bound CD40L on CD4+ T cells in women with primary Sjögren's syndrome. Scandinavian Journal of Immunology. 79: 37-42. PMID 24117612 DOI: 10.1111/Sji.12121 |
0.79 |
|
| 2014 |
Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, Delassus JL, Falgarone G, Guillevin L, Le Guern V, Lhote F, Meyer O, Ramanoelina J, Sacré K, Uzunhan Y, ... ... Mariette X, et al. Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area. Arthritis Care & Research. 66: 454-63. PMID 23983119 DOI: 10.1002/Acr.22115 |
0.311 |
|
| 2014 |
Seror R, Baron G, Hachulla E, Debandt M, Larroche C, Puéchal X, Maurier F, de Wazieres B, Quéméneur T, Ravaud P, Mariette X. Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial. Annals of the Rheumatic Diseases. 73: 2074-81. PMID 23897775 DOI: 10.1136/Annrheumdis-2013-203586 |
0.304 |
|
| 2014 |
Mariette X, Rouanet S, Sibilia J, Combe B, Le Loët X, Tebib J, Jourdan R, Dougados M. Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial. Annals of the Rheumatic Diseases. 73: 1508-14. PMID 23723317 DOI: 10.1136/Annrheumdis-2013-203480 |
0.312 |
|
| 2014 |
Nocturne G, Boudaoud S, Besson C, Davi F, Canioni D, Cacoub P, Hermine O, Mariette X. Genetic Variants of TNFAIP3 in Patients with HCV Related Lymphoma Are Associated with the Presence of Rheumatoid Factor (RF) Blood. 124: 1641-1641. DOI: 10.1182/Blood.V124.21.1641.1641 |
0.614 |
|
| 2014 |
Vallet H, Riviere S, Lambert M, Deroux A, Bielfeld P, Seve P, Fraison J, Perard L, Schoindre Y, Papo T, Kaplanski G, Sellam J, Le Hoang T, Fain O, Marie I, ... ... Mariette X, et al. SAT0269 Efficacy and Safety of Anti-TNF Alpha in BehÇEt Disease: Preliminary Results of A French Multicenter Registry of 92 Patients Annals of the Rheumatic Diseases. 73: 690.2-690. DOI: 10.1136/Annrheumdis-2014-Eular.5903 |
0.458 |
|
| 2014 |
Gottenberg J, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost J, Fauchais A, Goeb V, Hachulla E, Hatron P, Larroche C, Le Guern V, Morel J, Perdriger A, ... ... Mariette X, et al. OP0218 Elevated Serum BAFF is Associated with an Increased Risk of Developing A New Systemic Complication: Data from the Prospective ASSESS Cohort Annals of the Rheumatic Diseases. 73: 145.1-145. DOI: 10.1136/Annrheumdis-2014-Eular.4266 |
0.685 |
|
| 2014 |
Coenen M, Umićević Mirkov M, Krintel S, Johansen J, Miceli-Richard C, Källberg H, Padyukov L, Scheffer H, Kievit W, van de Laar M, van Riel P, Mariette X, Saevarsdottir S, Hetland M, Vermeulen S, et al. THU0478 Genome-Wide Association Analysis of Pain Reduction in Rheumatoid Arthritis Patients Treated with TNF Inhibitors Annals of the Rheumatic Diseases. 73: 348.3-348. DOI: 10.1136/Annrheumdis-2014-Eular.4094 |
0.51 |
|
| 2013 |
Nocturne G, Boudaoud S, Miceli-Richard C, Viengchareun S, Lazure T, Nititham J, Taylor KE, Ma A, Busato F, Melki J, Lessard CJ, Sivils KL, Dubost JJ, Hachulla E, Gottenberg JE, ... ... Mariette X, et al. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome. Blood. 122: 4068-76. PMID 24159176 DOI: 10.1182/Blood-2013-05-503383 |
0.798 |
|
| 2013 |
Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, Kelly JA, Dozmorov MG, Miceli-Richard C, Bowman S, Lester S, Eriksson P, Eloranta ML, Brun JG, Gøransson LG, ... ... Mariette X, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nature Genetics. 45: 1284-92. PMID 24097067 DOI: 10.1038/Ng.2792 |
0.582 |
|
| 2013 |
Lessard CJ, Li H, Adrianto I, Ice JA, Dozmorov MG, Jonsson R, Rischmueller M, Nordmark G, Mariette X, Miceli-Richard C, Wahren-Herlenius M, Witte T, Brennan MT, Omdal R, Rönnblom L, et al. Complex Functional Effects Within The HLA Contribute To Sjogren's Syndrome Pathogenesis and May Influence Both Transcriptional Regulation and Peptide Binding Arthritis & Rheumatism. 65. PMID 24085684 DOI: 10.1002/Art.38216 |
0.542 |
|
| 2013 |
Tobón GJ, Saraux A, Gottenberg JE, Quartuccio L, Fabris M, Seror R, Devauchelle-Pensec V, Morel J, Rist S, Mariette X, De Vita S, Youinou P, Pers JO. Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome. Arthritis and Rheumatism. 65: 3218-27. PMID 23982978 DOI: 10.1002/Art.38129 |
0.318 |
|
| 2013 |
Combe B, Rincheval N, Benessiano J, Berenbaum F, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loët X, Logeart I, Mariette X, et al. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. The Journal of Rheumatology. 40: 1650-7. PMID 23950185 DOI: 10.3899/Jrheum.121515 |
0.302 |
|
| 2013 |
Loulergue P, Tubach F, Salmon D, Dellamonica P, Taillan B, Thorel JB, Marteau P, Bressot C, Ravaud P, Mariette X, Lortholary O. Bacteremia in patients receiving TNF-alpha antagonists - A prospective multicenter study Journal of Infection. 67: 524-528. PMID 23921318 DOI: 10.1016/J.Jinf.2013.07.027 |
0.303 |
|
| 2013 |
Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, Sène D, Delahaye N, Vivier E, Chaba K, Poirier-Colame V, Nordmark G, Eloranta ML, Eriksson P, Theander E, ... ... Mariette X, et al. NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Science Translational Medicine. 5: 195ra96. PMID 23884468 DOI: 10.1126/Scitranslmed.3005727 |
0.73 |
|
| 2013 |
Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjögren's syndrome. Nature Reviews. Rheumatology. 9: 544-56. PMID 23857130 DOI: 10.1038/Nrrheum.2013.110 |
0.622 |
|
| 2013 |
Godot S, Gottenberg JE, Paternotte S, Pane I, Combe B, Sibilia J, Flipo RM, Schaeverbeke T, Ravaud P, Toussirot E, Berenbaum F, Mariette X, Wendling D, Sellam J. Safety of surgery after rituximab therapy in 133 patients with rheumatoid arthritis: Data from the autoimmunity and rituximab registry Arthritis Care and Research. 65: 1874-1879. PMID 23754822 DOI: 10.1002/Acr.22056 |
0.488 |
|
| 2013 |
Lanternier F, Tubach F, Ravaud P, Salmon D, Dellamonica P, Bretagne S, Couret M, Bouvard B, Debandt M, Gueit I, Gendre JP, Leone J, Nicolas N, Che D, Mariette X, et al. Incidence and risk factors of legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: A prospective French study Chest. 144: 990-998. PMID 23744173 DOI: 10.1378/Chest.12-2820 |
0.306 |
|
| 2013 |
Sellam J, Rouanet S, Hendel-Chavez H, Miceli-Richard C, Combe B, Sibilia J, Le Loët X, Tebib J, Jourdan R, Dougados M, Taoufik Y, Mariette X. CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis. Arthritis and Rheumatism. 65: 2253-61. PMID 23740460 DOI: 10.1002/Art.38023 |
0.65 |
|
| 2013 |
Gottenberg JE, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost JJ, Fauchais AL, Goeb V, Hachulla E, Hatron PY, Larroche C, Le Guern V, Morel J, Perdriger A, ... ... Mariette X, et al. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort. Plos One. 8: e59868. PMID 23717383 DOI: 10.1371/Journal.Pone.0059868 |
0.713 |
|
| 2013 |
Cui J, Stahl EA, Saevarsdottir S, Miceli C, Diogo D, Trynka G, Raj T, Mirkov MU, Canhao H, Ikari K, Terao C, Okada Y, Wedrén S, Askling J, Yamanaka H, ... ... Mariette X, et al. Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis. Plos Genetics. 9: e1003394. PMID 23555300 DOI: 10.1371/Journal.Pgen.1003394 |
0.365 |
|
| 2013 |
Seror R, Gottenberg JE, Devauchelle-Pensec V, Dubost JJ, Le Guern V, Hayem G, Fauchais AL, Goeb V, Hachulla E, Hatron PY, Larroche C, Morel J, Pedriger A, Puechal X, Rist S, ... ... Mariette X, et al. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients. Arthritis Care & Research. 65: 1358-64. PMID 23436737 DOI: 10.1002/Acr.21991 |
0.391 |
|
| 2013 |
Terrier B, Karras A, Kahn JE, Le Guenno G, Marie I, Benarous L, Lacraz A, Diot E, Hermine O, de Saint-Martin L, Cathébras P, Leblond V, Modiano P, Léger JM, Mariette X, et al. The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases. Medicine. 92: 61-8. PMID 23429354 DOI: 10.1097/Md.0B013E318288925C |
0.301 |
|
| 2013 |
Vitali C, Bootsma H, Bowman SJ, Dorner T, Gottenberg JE, Mariette X, Ramos-Casals M, Ravaud P, Seror R, Theander E, Tzioufas AG. Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue. Annals of the Rheumatic Diseases. 72: 476-8. PMID 23264355 DOI: 10.1136/Annrheumdis-2012-202565 |
0.305 |
|
| 2013 |
Gottenberg JE, Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, Pertuiset E, Kaplanski G, Chiche L, Berthelot JM, Gombert B, Goupille P, Marcelli C, Feuillet S, Leone J, ... ... Mariette X, et al. Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry. Annals of the Rheumatic Diseases. 72: 1026-31. PMID 23264337 DOI: 10.1136/Annrheumdis-2012-202293 |
0.354 |
|
| 2013 |
Umiċeviċ Mirkov M, Cui J, Vermeulen SH, Stahl EA, Toonen EJ, Makkinje RR, Lee AT, Huizinga TW, Allaart R, Barton A, Mariette X, Miceli CR, Criswell LA, Tak PP, de Vries N, et al. Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 72: 1375-81. PMID 23233654 DOI: 10.1136/Annrheumdis-2012-202405 |
0.373 |
|
| 2013 |
Jachiet M, Lependu C, Fragny D, Mariette X, Lepajolec C, Seror R. Severe deafness associated with Crohn's disease and spondylarthropathy: successful treatment with anti-TNF. Rheumatology (Oxford, England). 52: 1145-7. PMID 23221328 DOI: 10.1093/Rheumatology/Kes346 |
0.326 |
|
| 2013 |
Vincent FB, Morand EF, Murphy K, Mackay F, Mariette X, Marcelli C. Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective. Annals of the Rheumatic Diseases. 72: 165-78. PMID 23178294 DOI: 10.1136/Annrheumdis-2012-202545 |
0.323 |
|
| 2013 |
Seror R, Lazure T, Desmoulins F, Pavy S, Miceli-Richard C, Ravaud P, Mariette X. OP0113 Modification of Salivary Gland Lymphocyte Pattern after Belimumab in Primary Sjogren’s Syndrome: Results of the Beliss Study Annals of the Rheumatic Diseases. 72: A89.3-A90. DOI: 10.1136/Annrheumdis-2013-Eular.318 |
0.58 |
|
| 2013 |
Tost J, Touleimat N, Boudaoud S, Miceli C, Mariette X. OP0054 High-Throughput DNA Methylation Analysis of Cell Sorted Blood Cell Populations Reveals Widespread Epigenetic Deregulation in Sjogren’s Syndrome Annals of the Rheumatic Diseases. 72: A68.1-A68. DOI: 10.1136/Annrheumdis-2013-Eular.259 |
0.319 |
|
| 2013 |
Nocturne G, Boudaoud S, Miceli Richard C, Viengchareun S, Lazure T, Nititham J, Taylor KE, Criswell LA, Ma A, Busato F, Melki J, Dubost JJ, Hachulla E, Gottenberg JE, Lombes M, ... ... Mariette X, et al. OP0023 Germinal and Somatic Genetic Variants of TNFAIP3 Promote Lymphomagenesis Process Complicating Primary Sjögren’s Syndrome Annals of the Rheumatic Diseases. 72: A55.3-A56. DOI: 10.1136/Annrheumdis-2013-Eular.228 |
0.58 |
|
| 2013 |
Lessard CJ, Li H, Ice JA, Adrianto I, Jonsson R, Illei GG, Rischmueller M, Nordmark G, Mariette X, Miceli-Richard C, Wahren Herlenius M, Witte T, Brennan M, Omdal R, Gaffney PM, et al. OP0020 Identification of Multiple Sjögren’s Syndrome Susceptibility Loci Annals of the Rheumatic Diseases. 72: A54.3-A55. DOI: 10.1136/Annrheumdis-2013-Eular.225 |
0.555 |
|
| 2013 |
Combe B, Rincheval N, Benessiano J, Berenbaum F, Cantagrel A, Daures J-, Dougados M, Fardellone P, Fautrel B, Flipo R-, Goupille P, Guillemin F, Loet XL, Logeart I, Mariette X, et al. SAT0044 Five-Year Favourable Outcome of Patients with Early Rheumatoid Arthritis in the 2000S: Data from the Espoir Cohort Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.1770 |
0.341 |
|
| 2013 |
Sellam J, Rouanet S, Hendel-Chavez H, Marion-Thore S, Miceli-Richard C, Combe B, Sibilia J, Le Loët X, Tebib J, Chiocchia G, Jourdan R, Dougados M, Taoufik Y, Mariette X. FRI0247 Serum level of interleukin 33, a novel independent predictive biomarker of clinical response to rituximab in rheumatoid arthritis: results from the smart trial Annals of the Rheumatic Diseases. 72: A457.2-A457. DOI: 10.1136/Annrheumdis-2013-Eular.1374 |
0.68 |
|
| 2013 |
Salmon JH, Ravaud P, Bardin T, Cacoub P, Cantagruel A, Combe B, Dougados M, Flipo R, Godeau B, Guillevin L, Le Loët X, Hachulla E, Schaeverbeke T, Sibilia J, Pane I, ... ... Mariette X, et al. FRI0246 Serious infusion-related reactions after rituximab in patients with rheumatoid arthritis: data from the autoimmunity and rituximab registry Annals of the Rheumatic Diseases. 72: A457.1-A457. DOI: 10.1136/Annrheumdis-2013-Eular.1373 |
0.319 |
|
| 2013 |
Payet J, Seror R, Gottenberg J, Berger E, Desmoulins F, Meyer O, Mariette X. AB0679 One third of primary sjÖgren syndrome (PSS) patients with anti-CCP develop erosive rheumatoid arthritis (RA) after a 5-year follow-up Annals of the Rheumatic Diseases. 71: 677.11-677. DOI: 10.1136/Annrheumdis-2012-Eular.679 |
0.371 |
|
| 2013 |
Gottenberg J, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost J, Fauchais A, Goeb V, Hachulla E, Hatron P, Larroche C, Le Guern V, Morel J, Perdriger A, ... ... Mariette X, et al. SAT0226 Cigarette smoking in pss: association with earlier onset, male sex and serum baff increase in the assess cohort Annals of the Rheumatic Diseases. 71: 548.2-548. DOI: 10.1136/Annrheumdis-2012-Eular.3173 |
0.514 |
|
| 2013 |
Durez P, Miranda P, Toncheva A, Berman A, Rillo O, Boutsen Y, Kehler T, Mociran E, Soto Saez L, Fautrel B, Mariette X, Sokalov P, Lucero E, Vlak T, Grazio S, et al. FRI0152 Active therapeutic immunization with TNF-kinoid in rheumatoid arthritis patients with secondary resistance to tnfα antagonists is safe and immunogenic Annals of the Rheumatic Diseases. 71: 362.2-362. DOI: 10.1136/Annrheumdis-2012-Eular.2609 |
0.377 |
|
| 2013 |
Mariette X, Curtis J, Lee E, Riese R, Kaplan I, Chew R, Geier J, Wang L, Bradley J. THU0131 Tofacitinib (CP-690,550), an oral janus kinase inhibitor: Analysis of malignancies across the rheumatoid arthritis clinical programme Annals of the Rheumatic Diseases. 71: 199.2-199. DOI: 10.1136/Annrheumdis-2012-Eular.2096 |
0.321 |
|
| 2013 |
Godot S, Gottenberg J, Paternotte S, Pane I, Combe B, Sibilia J, Flipo R, Schaeverbeke T, Ravaud P, Toussirot E, Berenbaum F, Mariette X, Wendling D, Sellam J. THU0122 Safety of surgery in patients with rheumatoid arthritis treated by rituximab in routine care: Data from the french air registry: Annals of the Rheumatic Diseases. 71: 196.1-196. DOI: 10.1136/Annrheumdis-2012-Eular.2087 |
0.532 |
|
| 2013 |
Sellam J, Rouanet S, Hendel-Chavez H, Abbed K, Combe B, Sibilia J, Le Loët X, Tebib J, Jourdan R, Dougados M, Taoufik Y, Mariette X. THU0107 CCL19, a chemokine involved in B-cell trafficking, is related to the decrease of blood memory B-cells and predicts the clinical response to rituximab in rheumatoid arthritis: Results from the smart study Annals of the Rheumatic Diseases. 71: 190.2-190. DOI: 10.1136/Annrheumdis-2012-Eular.2072 |
0.555 |
|
| 2013 |
Nocturne G, Pavy S, Goupille P, Dougados M, Roux C, Mariette X, Miceli-Richard C. OP0094 DKK1 serum level is increased in recent spondyloarthritis and is associated with higher prevalence of syndesmophytes. Data from the desir cohort Annals of the Rheumatic Diseases. 71: 84.3-85. DOI: 10.1136/Annrheumdis-2012-Eular.1777 |
0.558 |
|
| 2012 |
Gestermann N, Koutero M, Belkhir R, Tost J, Mariette X, Miceli-Richard C. Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome. European Cytokine Network. 23: 166-72. PMID 23302156 DOI: 10.1684/Ecn.2012.0316 |
0.794 |
|
| 2012 |
Gottenberg JE, Dayer JM, Lukas C, Ducot B, Chiocchia G, Cantagrel A, Saraux A, Roux-Lombard P, Mariette X. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort. Annals of the Rheumatic Diseases. 71: 1243-8. PMID 22532637 DOI: 10.1136/Annrheumdis-2011-200975 |
0.35 |
|
| 2012 |
Glace B, Gottenberg JE, Mariette X, Philippe R, Pereira B, Lequerré T, Berthelot JM, Dougados M, Toussirot E, Pham T, Allanore Y, Loeuille D, Euller-Ziegler L, Soubrier M. Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry). Annals of the Rheumatic Diseases. 71: 1429-31. PMID 22504557 DOI: 10.1136/Annrheumdis-2011-200915 |
0.376 |
|
| 2012 |
Terrier B, Krastinova E, Marie I, Launay D, Lacraz A, Belenotti P, de Saint-Martin L, Quemeneur T, Huart A, Bonnet F, Le Guenno G, Kahn JE, Hinschberger O, Rullier P, Diot E, ... ... Mariette X, et al. Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey. Blood. 119: 5996-6004. PMID 22474249 DOI: 10.1182/Blood-2011-12-396028 |
0.329 |
|
| 2012 |
Seror R, Bootsma H, Bowman SJ, Dörner T, Gottenberg JE, Mariette X, Ramos-Casals M, Ravaud P, Theander E, Tzioufas A, Vitali C. Outcome measures for primary Sjögren's syndrome. Journal of Autoimmunity. 39: 97-102. PMID 22365784 DOI: 10.1016/J.Jaut.2012.01.013 |
0.342 |
|
| 2012 |
Mariette X. How does BAFF activate B cells in patients with autoimmune diseases? Arthritis Research & Therapy. 14: 106. PMID 22360881 DOI: 10.1186/Ar3729 |
0.353 |
|
| 2012 |
Boyer JF, Bongard V, Cantagrel A, Jamard B, Gottenberg JE, Mariette X, Davignon JL, Ferrières J, Ruidavets JB, Dallongeville J, Arveiler D, Cambon-Thomsen A, Constantin A. Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: results from a French multicenter cohort. Arthritis Care & Research. 64: 872-80. PMID 22275176 DOI: 10.1002/Acr.21623 |
0.322 |
|
| 2012 |
Mariette X, Baron G, Tubach F, Lioté F, Combe B, Miceli-Richard C, Flipo RM, Goupille P, Allez M, Salmon D, Emilie D, Carcelain G, Ravaud P. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy. Annals of the Rheumatic Diseases. 71: 1783-90. PMID 22258485 DOI: 10.1136/Annrheumdis-2011-200408 |
0.551 |
|
| 2012 |
Gottenberg JE, Mariette X. Primary Sjögren's syndrome: time for prospective cohorts. Current Pharmaceutical Biotechnology. 13: 2022-5. PMID 22208655 DOI: 10.2174/138920112802273128 |
0.358 |
|
| 2012 |
Serac G, Tubach F, Mariette X, Salmon-Céron D, Ravaud P, Lioté F, Laharie D, Ziza JM, Marguerie L, Bonnet C, Falgarone G, Nicolas N, Lortholary O, Chosidow O. Risk of herpes zoster in patients receiving anti-TNF-α in the prospective French RATIO registry. The Journal of Investigative Dermatology. 132: 726-9. PMID 22113472 DOI: 10.1038/Jid.2011.383 |
0.323 |
|
| 2012 |
Puéchal X, Gottenberg JE, Berthelot JM, Gossec L, Meyer O, Morel J, Wendling D, de Bandt M, Houvenagel E, Jamard B, Lequerré T, Morel G, Richette P, Sellam J, Guillevin L, ... Mariette X, et al. Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry. Arthritis Care & Research. 64: 331-9. PMID 22076726 DOI: 10.1002/Acr.20689 |
0.547 |
|
| 2012 |
Mariette X. Les nouveautés physiopathologiques à la base de la révolution thérapeutique des biothérapies dans les rhumatismes inflammatoires Bulletin De L'AcadéMie Nationale De MéDecine. 196: 1261-1278. DOI: 10.1016/S0001-4079(19)31709-1 |
0.307 |
|
| 2012 |
Nocturne G, Seror R, Dubost J, Goeb V, Le Quellec A, Bienvenu B, Roux C, Hachulla E, Le Guern V, Saraux A, Gottenberg J, Mariette X. Étude de 44 cas de lymphome compliquant un syndrome de Sjögren primitif (SSp) La Revue De MéDecine Interne. 33: A34-A35. DOI: 10.1016/J.Revmed.2012.10.024 |
0.509 |
|
| 2012 |
Cinquetti G, Larroche C, Combe B, Hachulla E, Meyer O, Pertuiset E, Kaplanski G, Mariette X, Gottenberg J. Efficacité du rituximab sur les manifestations systémiques du syndrome de Gougerot-Sjögren primitif : résultats sur 78 patients du registre AIR La Revue De MéDecine Interne. 33: S43. DOI: 10.1016/J.Revmed.2012.03.019 |
0.345 |
|
| 2011 |
Sellam J, Rouanet S, Hendel-Chavez H, Abbed K, Sibilia J, Tebib J, Le Loët X, Combe B, Dougados M, Mariette X, Taoufik Y. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis. Arthritis and Rheumatism. 63: 3692-701. PMID 22127692 DOI: 10.1002/Art.30599 |
0.559 |
|
| 2011 |
Mekinian A, Tamouza R, Pavy S, Gestermann N, Ittah M, Mariette X, Miceli-Richard C. Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis. European Cytokine Network. 22: 88-102. PMID 21768061 DOI: 10.1684/Ecn.2011.0285 |
0.764 |
|
| 2011 |
Nocturne G, Pavy S, Lazure T, Taoufik Y, Miceli C, Mariette X. IgG4 multiorgan lymphoproliferative syndrome as a differential diagnosis of primary Sjogren's syndrome in men? Annals of the Rheumatic Diseases. 70: 2234-5. PMID 21646415 DOI: 10.1136/Ard.2011.150367 |
0.584 |
|
| 2011 |
Rist S, Sellam J, Hachulla E, Sordet C, Puéchal X, Hatron PY, Benhamou CL, Sibilia J, Mariette X. Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjögren's syndrome: a national multicentric retrospective study. Arthritis Care & Research. 63: 1339-44. PMID 21584943 DOI: 10.1002/Acr.20495 |
0.54 |
|
| 2011 |
de Monchy I, Gendron G, Miceli C, Pogorzalek N, Mariette X, Labetoulle M. Combination of the Schirmer I and phenol red thread tests as a rescue strategy for diagnosis of ocular dryness associated with Sjögren's syndrome. Investigative Ophthalmology & Visual Science. 52: 5167-73. PMID 21546532 DOI: 10.1167/Iovs.10-6671 |
0.313 |
|
| 2011 |
Vallet H, Houitte R, Azria A, Mariette X. Cytomegalovirus colitis and hypo-IgG after rituximab therapy for rheumatoid arthritis. The Journal of Rheumatology. 38: 965-6. PMID 21532065 DOI: 10.3899/Jrheum.100818 |
0.349 |
|
| 2011 |
Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dörner T, Ferraccioli G, Gottenberg JE, Isaacs J, Kvien TK, Mariette X, Martin-Mola E, Pavelka K, Tak PP, van der Heijde D, et al. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 70: 909-20. PMID 21378402 DOI: 10.1136/Ard.2010.144998 |
0.301 |
|
| 2011 |
Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dörner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, et al. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Annals of the Rheumatic Diseases. 70: 968-72. PMID 21345815 DOI: 10.1136/Ard.2010.143743 |
0.355 |
|
| 2011 |
Sellam J, Hendel-Chavez H, Rouanet S, Abbed K, Combe B, Le Loët X, Tebib J, Sibilia J, Taoufik Y, Dougados M, Mariette X. B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study. Arthritis and Rheumatism. 63: 933-8. PMID 21225699 DOI: 10.1002/Art.30233 |
0.562 |
|
| 2011 |
Ittah M, Miceli-Richard C, Lebon P, Pallier C, Lepajolec C, Mariette X. Induction of B cell-activating factor by viral infection is a general phenomenon, but the types of viruses and mechanisms depend on cell type. Journal of Innate Immunity. 3: 200-7. PMID 21051868 DOI: 10.1159/000321194 |
0.776 |
|
| 2011 |
Borie R, Schneider S, Debray MP, Adle-Biasssette H, Danel C, Bergeron A, Mariette X, Aubier M, Papo T, Crestani B. Severe chronic bronchiolitis as the presenting feature of primary Sjögren's syndrome. Respiratory Medicine. 105: 130-6. PMID 21050739 DOI: 10.1016/J.Rmed.2010.07.017 |
0.31 |
|
| 2011 |
Pers J, Tobon GJ, Gottenberg J, Seror R, Devauchelle-Pensec V, Morel J, Rist S, Mariette X, Saraux A, Youinou P. Excessive FMS-like tyrosine kinase3-ligand heralds lymphoma in primary sjogren's syndrome Annals of the Rheumatic Diseases. 70: A59-A59. DOI: 10.1136/Ard.2010.149005.5 |
0.384 |
|
| 2011 |
Nishikawa M, Owaki H, Fuji T, Soliman MM, Ashcroft DM, Watson KD, Lunt M, Symmons D, Hyrich KL, Atkinson F, Malik S, Heycock C, Saravanan V, Rynne M, Hamilton J, ... ... Mariette X, et al. Rheumatoid arthritis - treatment 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis Rheumatology. 50. DOI: 10.1093/Rheumatology/Ker031 |
0.336 |
|
| 2011 |
Rivoisy C, Nicolas N, Salmon D, Sereni D, Carcelain G, Mariette X, Tubach F, Bourgarit A. PARADOXICAL RESPONSE IN THE TREATMENT OF TUBERCULOSIS AFTER DISCONTINUATION OF ANTI TNF IN PATIENTS WITH INFLAMMATORY DISEASES: A CASE-SERIES European Journal of Internal Medicine. 22: S12-S13. DOI: 10.1016/S0953-6205(11)60048-4 |
0.322 |
|
| 2011 |
Rivoisy C, Nicolas N, Salmon D, Lortholary O, Mariette X, Tubach F, Bourgarit A. Facteurs de risque du syndrome de reconstitution immunitaire de tuberculoses acquises sous anti-TNFα : étude cas–témoins La Revue De MéDecine Interne. 32: S269-S270. DOI: 10.1016/J.Revmed.2011.10.311 |
0.334 |
|
| 2011 |
Maldini C, Seror R, Fain O, Dhote R, Leroux J, Guillevin L, Mariette X, Mahr A. Épidémiologie du syndrome de Gougerot-Sjögren (SGS) primitif dans le département de la Seine-Saint-Denis en 2007 La Revue De MéDecine Interne. 32: S255. DOI: 10.1016/J.Revmed.2011.10.282 |
0.31 |
|
| 2010 |
Salmon-Ceron D, Tubach F, Lortholary O, Chosidow O, Bretagne S, Nicolas N, Cuillerier E, Fautrel B, Michelet C, Morel J, Puéchal X, Wendling D, Lemann M, Ravaud P, Mariette X. Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Annals of the Rheumatic Diseases. 70: 616-23. PMID 21177290 DOI: 10.1136/Ard.2010.137422 |
0.315 |
|
| 2010 |
Mariette X, Gottenberg JE. Pathogenesis of Sjögren's syndrome and therapeutic consequences. Current Opinion in Rheumatology. 22: 471-7. PMID 20671520 DOI: 10.1097/Bor.0B013E32833C36C5 |
0.307 |
|
| 2010 |
Gestermann N, Mekinian A, Comets E, Loiseau P, Puechal X, Hachulla E, Gottenberg JE, Mariette X, Miceli-Richard C. STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling. Genes and Immunity. 11: 432-8. PMID 20535138 DOI: 10.1038/Gene.2010.29 |
0.792 |
|
| 2010 |
Terrier B, Amoura Z, Ravaud P, Hachulla E, Jouenne R, Combe B, Bonnet C, Cacoub P, Cantagrel A, de Bandt M, Fain O, Fautrel B, Gaudin P, Godeau B, Harlé JR, ... ... Mariette X, et al. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. Arthritis and Rheumatism. 62: 2458-66. PMID 20506527 DOI: 10.1002/Art.27541 |
0.303 |
|
| 2010 |
Gottenberg JE, Ravaud P, Bardin T, Cacoub P, Cantagrel A, Combe B, Dougados M, Flipo RM, Godeau B, Guillevin L, Le Loët X, Hachulla E, Schaeverbeke T, Sibilia J, Baron G, ... Mariette X, et al. Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Arthritis and Rheumatism. 62: 2625-32. PMID 20506353 DOI: 10.1002/Art.27555 |
0.334 |
|
| 2010 |
Mariette X. Lymphoma, rheumatoid arthritis, and TNFalpha antagonists. Joint Bone Spine. 77: 195-7. PMID 20399132 DOI: 10.1016/J.Jbspin.2010.02.002 |
0.311 |
|
| 2010 |
Seror R, Mariette X, Bowman S, Baron G, Gottenberg JE, Bootsma H, Boostma H, Theander E, Tzioufas A, Vitali C, Ravaud P. Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index. Arthritis Care & Research. 62: 551-8. PMID 20391511 DOI: 10.1002/Acr.20173 |
0.764 |
|
| 2010 |
Nocturne G, Dougados M, Constantin A, Richez C, Sellam J, Simon A, Wendling D, Mariette X, Gottenberg JE. Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry. Annals of the Rheumatic Diseases. 69: 471-2. PMID 20107035 DOI: 10.1136/ard.2008.107102 |
0.646 |
|
| 2010 |
Pavy S, Toonen EJ, Miceli-Richard C, Barrera P, van Riel PL, Criswell LA, Mariette X, Coenen MJ. Tumour necrosis factor alpha -308G->A polymorphism is not associated with response to TNFalpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis. Annals of the Rheumatic Diseases. 69: 1022-8. PMID 19966089 DOI: 10.1136/Ard.2009.117622 |
0.607 |
|
| 2010 |
Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C. EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Annals of the Rheumatic Diseases. 69: 1103-9. PMID 19561361 DOI: 10.1136/Ard.2009.110619 |
0.359 |
|
| 2010 |
Gestermann N, Mekinian A, Comets E, Loiseau P, Puechal X, Hachulla E, Gottenberg J, Mariette X, Miceli-Richard C. Erratum: STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling Genes & Immunity. 11: 446-446. DOI: 10.1038/gene.2010.38 |
0.781 |
|
| 2010 |
Mekinian A, Hachulla E, Larroche C, Leone J, Gomberg B, Hamidou M, Cantagrel A, Marcelli C, Breban M, Fain O, Gottenberg J, Mariette X. Efficacité du rituximab dans les atteintes neurologiques périphériques du syndrome de Sjögren primaire : les données du registre français AIR La Revue De MéDecine Interne. 31: S357. DOI: 10.1016/J.Revmed.2010.10.043 |
0.304 |
|
| 2010 |
Le Guen J, Pagnoux C, Néel A, Roubaut C, Gottenberg J, Hamidou M, Dehais J, Wendling D, Amoura Z, Cacoub P, Mariette X, Guillevin L. Tolérance et efficacité du rituximab en traitement des vascularites systémiques nécrosantes. Étude des 33 patients du registre auto-immunité rituximab (AIR) La Revue De MéDecine Interne. 31: S74. DOI: 10.1016/J.Revmed.2010.03.434 |
0.302 |
|
| 2009 |
Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Research & Therapy. 11: R156. PMID 19832990 DOI: 10.1186/Ar2833 |
0.795 |
|
| 2009 |
Mariette X, Tubach F, Bagheri H, Bardet M, Berthelot JM, Gaudin P, Heresbach D, Martin A, Schaeverbeke T, Salmon D, Lemann M, Hermine O, Raphael M, Ravaud P. Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Annals of the Rheumatic Diseases. 69: 400-8. PMID 19828563 DOI: 10.1136/Ard.2009.117762 |
0.328 |
|
| 2009 |
Soubrier M, Puéchal X, Sibilia J, Mariette X, Meyer O, Combe B, Flipo RM, Mulleman D, Berenbaum F, Zarnitsky C, Schaeverbeke T, Fardellone P, Dougados M. Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial. Rheumatology (Oxford, England). 48: 1429-34. PMID 19741011 DOI: 10.1093/Rheumatology/Kep261 |
0.314 |
|
| 2009 |
Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X. Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort. Arthritis Research & Therapy. 11: R114. PMID 19627580 DOI: 10.1186/Ar2773 |
0.611 |
|
| 2009 |
Miceli-Richard C, Gestermann N, Ittah M, Comets E, Loiseau P, Puechal X, Hachulla E, Gottenberg JE, Lebon P, Becquemont L, Mariette X. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome. Arthritis and Rheumatism. 60: 1991-7. PMID 19565491 DOI: 10.1002/Art.24662 |
0.787 |
|
| 2009 |
Jacquet A, Francois H, Frangie C, Yahiaoui Y, Ferlicot S, Micelli C, Mariette X, Durrbach A. IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 24: 3540-2. PMID 19556300 DOI: 10.1093/Ndt/Gfp314 |
0.314 |
|
| 2009 |
Tebib J, Mariette X, Bourgeois P, Flipo RM, Gaudin P, Le Loët X, Gineste P, Guy L, Mansfield CD, Moussy A, Dubreuil P, Hermine O, Sibilia J. Masitinib in the treatment of active rheumatoid arthritis: Results of a multicentre, open-label, dose-ranging, phase 2a study Arthritis Research and Therapy. 11. PMID 19549290 DOI: 10.1186/Ar2740 |
0.318 |
|
| 2009 |
Miceli-Richard C, Gestermann N, Amiel C, Sellam J, Ittah M, Pavy S, Urrutia A, Girauld I, Carcelain G, Venet A, Mariette X. Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies. Arthritis Research & Therapy. 11: R77. PMID 19470150 DOI: 10.1186/Ar2708 |
0.793 |
|
| 2009 |
Ittah M, Miceli-Richard C, Gottenberg JE, Sellam J, Lepajolec C, Mariette X. B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation. European Journal of Immunology. 39: 1271-9. PMID 19337998 DOI: 10.1002/Eji.200839086 |
0.784 |
|
| 2009 |
Mariette X. Therapeutic potential for B-cell modulation in Sjögren's syndrome. Rheumatic Diseases Clinics of North America. 34: 1025-33, x. PMID 18984420 DOI: 10.1016/J.Rdc.2008.08.014 |
0.347 |
|
| 2009 |
Nicolas N, Mariette X, Tubach F, Michelet C, Dellamonica P, Lortholary O, Salmon D. COL2-04 Risque d’infections opportunistes (IO) sous traitement par anti TNF α : résultats finaux des 3 ans de surveillance de l’observatoire RATIO MéDecine Et Maladies Infectieuses. 39: S2. DOI: 10.1016/S0399-077X(09)74269-6 |
0.309 |
|
| 2009 |
Seror R, Mariette X, Bowman S, Baron G, Gottenberg J, Boostma H, Theander E, Tzioufas A, Vitali C, Ravaud P. Le score EULAR Sjögren's syndrome disease activity index (ESSDAI) détecte les changements de niveau d’activité de façon plus adéquate que les autres scores d’activité dans le syndrome de Sjögren primitif (Sjp) Revue D'éPidéMiologie Et De Santé Publique. 57: S55. DOI: 10.1016/J.Respe.2009.02.190 |
0.339 |
|
| 2009 |
Seror R, Vitali C, Bowman S, Baron G, Tzioufas A, Theander E, Gottenberg J, Boostma H, Mariette X, Ravaud P. Eular Sjögren's syndrome activity index. Développement d’un score d’activité systémique pour les patients atteints d’un syndrome de Sjögren primitif (Sjp) Revue D'éPidéMiologie Et De Santé Publique. 57: S54. DOI: 10.1016/J.Respe.2009.02.189 |
0.359 |
|
| 2008 |
Smedby KE, Askling J, Mariette X, Baecklund E. Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update. Journal of Internal Medicine. 264: 514-27. PMID 19017176 DOI: 10.1111/J.1365-2796.2008.02029.X |
0.319 |
|
| 2008 |
Sibilia J, Gottenberg JE, Mariette X. Rituximab: a new therapeutic alternative in rheumatoid arthritis. Joint Bone Spine. 75: 526-32. PMID 18571968 DOI: 10.1016/J.Jbspin.2008.02.009 |
0.368 |
|
| 2008 |
Ittah M, Miceli-Richard C, Gottenberg JE, Sellam J, Eid P, Lebon P, Pallier C, Lepajolec C, Mariette X. Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways. European Journal of Immunology. 38: 1058-64. PMID 18350548 DOI: 10.1002/Eji.200738013 |
0.794 |
|
| 2008 |
Sellam J, Miceli-Richard C, Gottenberg JE, Proust A, Ittah M, Lavie F, Loiseau P, Mariette X. Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome? Rheumatology (Oxford, England). 47: 437-41. PMID 18296721 DOI: 10.1093/Rheumatology/Ken013 |
0.794 |
|
| 2008 |
Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome. Scandinavian Journal of Immunology. 67: 185-92. PMID 18201372 DOI: 10.1111/J.1365-3083.2007.02049.X |
0.799 |
|
| 2008 |
Eymard C, Ben M’Rad M, Tubach F, Mariette X, Lortholary O, Salmon D. U-05 Listérioses sous anti-TNF : résultats de 3 ans de surveillance de l’observatoire RATIO MéDecine Et Maladies Infectieuses. 38: S187. DOI: 10.1016/S0399-077X(08)73241-4 |
0.306 |
|
| 2008 |
Cobb B, Kaufman K, Wang Y, Kelly J, Jonsson R, Bolstad AI, Brun J, Rischmueller M, Lester S, Witte T, Mariette X, Kimberly R, Edberg J, Bae S, Jacob C, et al. OR.104. Association of Sjögren's Syndrome (SS) and Systemic Lupus Erythematosus (SLE) with BLK Clinical Immunology. 127: S41. DOI: 10.1016/J.Clim.2008.03.111 |
0.339 |
|
| 2007 |
Pham T, Fautrel B, Dernis E, Goupille P, Guillemin F, Le Loët X, Ravaud P, Claudepierre P, Miceli-Richard C, de Bandt M, Breban M, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, ... ... Mariette X, et al. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 638-46. PMID 18065252 DOI: 10.1016/J.Jbspin.2007.10.003 |
0.574 |
|
| 2007 |
Miceli-Richard C, Comets E, Loiseau P, Puechal X, Hachulla E, Mariette X. Association of an IRF5 gene functional polymorphism with Sjögren's syndrome. Arthritis and Rheumatism. 56: 3989-94. PMID 18050197 DOI: 10.1002/Art.23142 |
0.601 |
|
| 2007 |
Terrier B, Lacroix C, Guillevin L, Hatron PY, Dhote R, Maillot F, Diot E, Sarrot-Reynauld F, Sordet C, Dubourg O, Meyer L, Mariette X, Gottenberg JE. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjögren's syndrome-related neuropathy. Arthritis and Rheumatism. 57: 1520-9. PMID 18050172 DOI: 10.1002/Art.23102 |
0.337 |
|
| 2007 |
Puéchal X, Miceli-Richard C, Mejjad O, Lafforgue P, Marcelli C, Solau-Gervais E, Steinfeld S, Villoutreix C, Trèves R, Mariette X, Guillevin L. Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Annals of the Rheumatic Diseases. 67: 880-4. PMID 18037625 DOI: 10.1136/Ard.2007.081679 |
0.606 |
|
| 2007 |
Fautrel B, Pham T, Mouterde G, Le Loët X, Goupille P, Guillemin F, Ravaud P, Cantagrel A, Dougados M, Puéchal X, Sibilia J, Soubrier M, Mariette X, Combe B, et al. Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 627-37. PMID 18037319 DOI: 10.1016/J.Jbspin.2007.10.001 |
0.316 |
|
| 2007 |
Miceli-Richard C, Dieude P, Hachulla E, Puechal X, Cornelis F, Mariette X. Tumour necrosis factor receptor 2 (TNFRSF1B) association study in Sjögren's syndrome. Annals of the Rheumatic Diseases. 66: 1684-5. PMID 17998218 DOI: 10.1136/Ard.2007.071167 |
0.603 |
|
| 2007 |
Miceli-Richard C, Mariette X. EBV-specific T-cell response and immunosuppression by methotrexate and TNFalpha antagonists in patients with chronic inflammatory joint disease. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 560-2. PMID 17988922 DOI: 10.1016/J.Jbspin.2007.09.002 |
0.591 |
|
| 2007 |
Salliot C, Gottenberg JE, Bengoufa D, Desmoulins F, Miceli-Richard C, Mariette X. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome. The Journal of Rheumatology. 34: 2253-8. PMID 17937465 |
0.559 |
|
| 2007 |
Combe B, Benessiano J, Berenbaum F, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loet X, Logeart I, Mariette X, Meyer O, et al. The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 440-5. PMID 17905631 DOI: 10.1016/J.Jbspin.2007.06.001 |
0.329 |
|
| 2007 |
Sellam J, Costedoat-Chalumeau N, Amoura Z, Aymard G, Choquet S, Trad S, Vignes BL, Hulot JS, Berenbaum F, Lechat P, Cacoub P, Ankri A, Mariette X, Leblond V, Piette JC. Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 446-52. PMID 17692552 DOI: 10.1016/J.Jbspin.2006.12.006 |
0.511 |
|
| 2007 |
Miceli-Richard C, Comets E, Verstuyft C, Tamouza R, Loiseau P, Ravaud P, Kupper H, Becquemont L, Charron D, Mariette X. A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis. Annals of the Rheumatic Diseases. 67: 478-84. PMID 17673491 DOI: 10.1136/Ard.2007.074104 |
0.581 |
|
| 2007 |
Pavy S, Dernis E, Lavie F, Maillefert JF, Mariette X, Schaeverbeke T, Cantagrel A, Claudepierre P, Flipo RM, Goupille P, Le Loet X, Saraux A, Tebib J, Wendling D, Combe B. Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 338-45. PMID 17591453 DOI: 10.1016/J.Jbspin.2007.04.001 |
0.639 |
|
| 2007 |
Lavie F, Pavy S, Dernis E, Goupille P, Cantagrel A, Tebib J, Claudepierre P, Flipo RM, Le Loët X, Maillefert JF, Mariette X, Saraux A, Schaeverbeke T, Wendling D, Combe B. Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 346-52. PMID 17590370 DOI: 10.1016/J.Jbspin.2007.04.003 |
0.643 |
|
| 2007 |
Dernis E, Lavie F, Pavy S, Wendling D, Flipo RM, Saraux A, Cantagrel A, Claudepierrre P, Goupille P, Le Loët X, Maillefert JF, Mariette X, Schaeverbeke T, Tebib J, Combe B. Clinical and laboratory follow-up for treating and monitoring patients with ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 330-7. PMID 17590366 DOI: 10.1016/J.Jbspin.2007.04.002 |
0.649 |
|
| 2007 |
Sellam J, Hamdi H, Roy C, Baron G, Lemann M, Puéchal X, Breban M, Berenbaum F, Humbert M, Weldingh K, Salmon D, Ravaud P, Emilie D, Mariette X. Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy. Annals of the Rheumatic Diseases. 66: 1610-5. PMID 17456528 DOI: 10.1136/Ard.2007.069799 |
0.502 |
|
| 2007 |
Terrier B, Ittah M, Tourneur L, Louache F, Soumelis V, Lavie F, Casadevall N, Candon S, Hummel A, Mariette X, Buzyn A. Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery. Haematologica. 92: e20-3. PMID 17405749 DOI: 10.3324/Haematol.11031 |
0.801 |
|
| 2007 |
Gottenberg JE, Loiseau P, Azarian M, Chen C, Cagnard N, Hachulla E, Puechal X, Sibilia J, Charron D, Mariette X, Miceli-Richard C. CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome Arthritis Research and Therapy. 9. PMID 17341301 DOI: 10.1186/Ar2136 |
0.567 |
|
| 2007 |
Burmester GR, Mariette X, Montecucco C, Monteagudo-Sáez I, Malaise M, Tzioufas AG, Bijlsma JW, Unnebrink K, Kary S, Kupper H. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial. Annals of the Rheumatic Diseases. 66: 732-9. PMID 17329305 DOI: 10.1136/Ard.2006.066761 |
0.31 |
|
| 2007 |
Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Annals of the Rheumatic Diseases. 66: 790-7. PMID 17185325 DOI: 10.1136/Ard.2006.065656 |
0.804 |
|
| 2007 |
Lazure T, Miceli-Richard C, Sellam J, Fabre M, Mariette X, Guettier C. Small hepatic vein involvement in IgG multiple myeloma: a very unusual pattern of liver infiltration. Virchows Archiv : An International Journal of Pathology. 450: 127-9. PMID 17111130 DOI: 10.1007/S00428-006-0297-Z |
0.618 |
|
| 2007 |
Lavie F, Miceli-Richard C, Ittah M, Sellam J, Gottenberg JE, Mariette X. Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production. Annals of the Rheumatic Diseases. 66: 700-3. PMID 17040963 DOI: 10.1136/Ard.2006.060772 |
0.788 |
|
| 2007 |
Seror R, Sordet C, Guillevin L, Hachulla E, Masson C, Ittah M, Candon S, Le Guern V, Aouba A, Sibilia J, Gottenberg JE, Mariette X. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 66: 351-7. PMID 16950808 DOI: 10.1136/Ard.2006.057919 |
0.748 |
|
| 2007 |
Miceli-Richard C, Gottenberg J, Mariette X. CTLA-4 polymorphism and primary Sjögren's syndrome: authors' response Arthritis Research & Therapy. 9: 402. DOI: 10.1186/Ar2199 |
0.6 |
|
| 2007 |
Pham T, Fautrel B, Dernis E, Goupille P, Guillemin F, Le Loët X, Ravaud P, Claudepierre P, Miceli-Richard C, De Bandt M, Breban M, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, ... ... Mariette X, et al. Recommendations of the French Society for Rheumatology Regarding TNF α; antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update{lozenge, open}{lozenge, open}Pour citer cet article, utiliser ce titre en anglais et sa référence dans le même volume de Joint Bone Spine. | Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNF dans la spondylarthrite ankylosante et le rhumatisme psoriasique : mise à jour 2007 Revue Du Rhumatisme (Edition Francaise). 74: 1312-1322. DOI: 10.1016/J.Rhum.2007.10.612 |
0.57 |
|
| 2007 |
Sellam J, Miceli Richard C, Proust A, Ittah M, Lavie F, Gottenberg J, Loiseau P, Mariette X. Le gène Id3 est-il impliqué dans le syndrome de Sjögren? Revue Du Rhumatisme. 74: 1019-1020. DOI: 10.1016/J.Rhum.2007.10.553 |
0.781 |
|
| 2007 |
Ittah M, Richard CM, Gottenberg J, Sellam J, Eid P, Lebon P, Lepagolec C, Mariette X. BAFF (B-cell activating Factor) est secrétée directement par les cellules épithéliales salivaires après infection virale via des voies TLR3 et interféron de type I – dépendantes et –indépendantes Revue Du Rhumatisme. 74: 1019. DOI: 10.1016/J.Rhum.2007.10.551 |
0.752 |
|
| 2007 |
Miceli-Richard C, Gottenberg J, Combe B, Mariette X. Recherche d'association du polymorphisme -871 T/C du promoteur de BAFF avec la polyarthrite rhumatoïde – Etudes de corrélation avec le niveau d'expression sérique de BAFF, l'activité et la sévérité structurale initiale de la maladie (Cohorte ESPOIR) Revue Du Rhumatisme. 74: 998. DOI: 10.1016/J.Rhum.2007.10.500 |
0.5 |
|
| 2007 |
Gottenberg J, Miceli-Richard C, Goupille P, Rincheval N, Combe B, Mariette X. Au cours des PR récentes, les biomarqueurs lymphocytaires B sont augmentés indépendamment de BAFF, corrélés au DAS28 et associés aux lésions radiologiques précoces: résultats de la cohorte ESPOIR Revue Du Rhumatisme. 74: 971. DOI: 10.1016/J.Rhum.2007.10.444 |
0.505 |
|
| 2007 |
Chauffier K, Gottenberg J, Sellam J, Salama L, Azria A, Clerc D, Richard CM, Mariette X. Manifestations inhabituelles révélant un myélome multiple Revue Du Rhumatisme. 74: 1170. DOI: 10.1016/J.Rhum.2007.10.340 |
0.41 |
|
| 2007 |
Miceli-Richard C, Mariette X. Réponse spécifique T anti-Epstein-Barr virus et traitements par méthotrexate et anti-TNFα chez les patients atteints de rhumatismes inflammatoires chroniques Revue Du Rhumatisme. 74: 963-965. DOI: 10.1016/J.Rhum.2007.09.001 |
0.576 |
|
| 2007 |
Gottenberg J, Mariette X. Actualités sur la physiopathologie du syndrome de Gougerot-Sjögren Revue Du Rhumatisme. 74: 732-736. DOI: 10.1016/J.Rhum.2007.05.003 |
0.319 |
|
| 2007 |
Pham T, Fautrel B, Dernis E, Goupille P, Guillemin F, Le Loët X, Ravaud P, Claudepierre P, Miceli-Richard C, de Bandt M, Breban M, Maillefert J, Masson C, Saraux A, Schaeverbeke T, ... ... Mariette X, et al. Mise à jour des recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα chez les personnes souffrant de spondylarthrite ankylosante (SA) et de rhumatisme psoriasique (RP) Revue Du Rhumatisme. 74: 531. DOI: 10.1016/J.Rhum.2007.02.007 |
0.504 |
|
| 2007 |
Sellam J, Costedoat-Chalumeau N, Amoura Z, Aymard G, Choquet S, Trad S, Vignes BL, Hulot J, Berenbaum F, Lechat P, Cacoub P, Ankri A, Mariette X, Leblond V, Piette J. Potentialisation de la fluindione et de la warfarine par la dexaméthasone dans le myélome multiple et l'amylose AL Revue Du Rhumatisme. 74: 845-851. DOI: 10.1016/J.Rhum.2006.12.012 |
0.496 |
|
| 2007 |
Costedoat-Chalumeau N, Leroux G, Sellam J, Amoura Z, Hulot J, Aymard G, Lechat P, Mariette X, Piette J. Étude de la pharmacocinétique de l'hydroxychloroquine chez cinq patients traités par une posologie alternée de 1 ou deux comprimés par jour La Revue De MéDecine Interne. 28: 60. DOI: 10.1016/J.Revmed.2007.03.084 |
0.513 |
|
| 2006 |
Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, et al. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists. Arthritis Research & Therapy. 8: R114. PMID 16859506 DOI: 10.1186/Ar1994 |
0.327 |
|
| 2006 |
Pham T, Guillemin F, Claudepierre P, Luc M, Miceli-Richard C, Fautrel B, de Bandt M, Breban M, Goupille P, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, Wendling D, Mariette X, et al. TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology. Joint, Bone, Spine : Revue Du Rhumatisme. 73: 547-53. PMID 16843030 DOI: 10.1016/J.Jbspin.2006.02.005 |
0.549 |
|
| 2006 |
Gottenberg JE, Pallier C, Ittah M, Lavie F, Miceli-Richard C, Sellam J, Nordmann P, Cagnard N, Sibilia J, Mariette X. Failure to confirm coxsackievirus infection in primary Sjögren's syndrome. Arthritis and Rheumatism. 54: 2026-8. PMID 16732567 DOI: 10.1002/Art.21906 |
0.775 |
|
| 2006 |
Baran-Marszak F, Laguillier C, Youlyouz I, Feuillard J, Mariette X, Fagard R, Raphaël M. Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus. Cytokine. 33: 337-45. PMID 16713282 DOI: 10.1016/J.Cyto.2006.03.005 |
0.328 |
|
| 2006 |
Gottenberg JE, Aucouturier F, Goetz J, Sordet C, Jahn I, Busson M, Cayuela JM, Sibilia J, Mariette X. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome. Annals of the Rheumatic Diseases. 66: 23-7. PMID 16569685 DOI: 10.1136/Ard.2006.052159 |
0.334 |
|
| 2006 |
Ittah M, Miceli-Richard C, Eric Gottenberg J, Lavie F, Lazure T, Ba N, Sellam J, Lepajolec C, Mariette X. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome. Arthritis Research & Therapy. 8: R51. PMID 16507175 DOI: 10.1186/Ar1912 |
0.788 |
|
| 2006 |
Gottenberg JE, Sellam J, Ittah M, Lavie F, Proust A, Zouali H, Sordet C, Sibilia J, Kimberly RP, Mariette X, Miceli-Richard C. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome. Arthritis Research & Therapy. 8: R30. PMID 16507129 DOI: 10.1186/Ar1884 |
0.801 |
|
| 2006 |
Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, Jacques S, Ba N, Ittah M, Lepajolec C, Labetoulle M, Ardizzone M, Sibilia J, Fournier C, Chiocchia G, ... Mariette X, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proceedings of the National Academy of Sciences of the United States of America. 103: 2770-5. PMID 16477017 DOI: 10.1073/Pnas.0510837103 |
0.737 |
|
| 2006 |
Vauloup C, Krzysiek R, Greangeot-Keros L, Wendling D, Goupille P, Brault R, Brousse C, Mariette X, Emilie D. Effects of tumor necrosis factor antagonist treatment on hepatitis C-related immunological abnormalities European Cytokine Network. 17: 290-293. DOI: 10.1684/Ecn.2006.0046 |
0.315 |
|
| 2006 |
Lavie F, Ittah M, Miceli-Richard C, Gottenberg J, Sellam J, Mariette X. Expression anormale de BAFF au sein des monocytes et lymphocytes T circulants de patients ayant un syndrome de Sjögren primitif Revue Du Rhumatisme. 73: 1227. DOI: 10.1016/J.Rhum.2006.10.564 |
0.796 |
|
| 2006 |
Ittah M, Miceli-Richard C, Gottenberg J, Lavie F, Sellam J, Mariette X. Induction de la cytokine BAFF (B Cell-Activating Factor of the TNF family) par les cellules épithéliales de glandes salivaires après infection virale Revue Du Rhumatisme. 73: 1201-1202. DOI: 10.1016/J.Rhum.2006.10.487 |
0.791 |
|
| 2006 |
Gottenberg J, Jacques S, Ittah M, Miceli-Richard C, Lavie F, Sellam J, Mariette X. Un nouveau rôle pathogène des interférons au cours des maladies auto-immunes: l'augmentation du rapport BAFF/delta-BAFF dans les cellules cibles de l'auto-immunité Revue Du Rhumatisme. 73: 1201. DOI: 10.1016/J.Rhum.2006.10.485 |
0.765 |
|
| 2006 |
Gottenberg J, Loiseau P, Chun C, Azarian M, Cagnard N, Hachulla E, Puéchal X, Sibilia J, Charron D, Mariette X, Miceli-Richard C. Polymorphismes +49A/G et CT60 de CTLA-4 et prédisposition génétique au syndrome de Sjögren primitif Revue Du Rhumatisme. 73: 1200-1201. DOI: 10.1016/J.Rhum.2006.10.484 |
0.485 |
|
| 2006 |
Sellam J, Miceli-Richard C, Gottenberg J, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Expression du récepteur de BAFF (B cell Activator Factor of TNF Family), BAFF-R, au cours du syndrome de Sjögren primitif et du lupus systémique Revue Du Rhumatisme. 73: 1200. DOI: 10.1016/J.Rhum.2006.10.483 |
0.792 |
|
| 2006 |
Miceli-Richard C, Verstuyft C, Comets E, Ravaud P, Kupper H, Becquemont L, Mariette X. La co-administration de MTX au cours de la PR augmente significativement la réponse ACR50 à l'adalimumab (Etude ReAct) indépendamment des polymorphismes des gènes MDR1 (multidrug resistance 1) et MTHFR (methylenetetrahydrofolate reductase) Revue Du Rhumatisme. 73: 1165-1166. DOI: 10.1016/J.Rhum.2006.10.386 |
0.492 |
|
| 2006 |
Sellam J, Roy C, Baron G, Hamdi H, Ravaud P, Emilie D, Mariette X. Fallait il changer le seuil de positivité de l'intradermoréaction à la tuberculine au cours des maladies inflammatoires pour la mise sous anti-TNF? Revue Du Rhumatisme. 73: 1164. DOI: 10.1016/J.Rhum.2006.10.381 |
0.453 |
|
| 2006 |
Miceli-Richard C, Ohresser M, Comets E, Goupille P, Verstuyft C, Ravaud P, Kupper H, Watier H, Mariette X. Analyse des polymorphismes des gènes des récepteurs FcgIIA, -IIIB et -IIIB comme facteurs prédictifs de la réponse à l'adalimumab (Etude ReAct) au cours de la polyarthrite rhumatoïde Revue Du Rhumatisme. 73: 1094. DOI: 10.1016/J.Rhum.2006.10.176 |
0.493 |
|
| 2006 |
Lavie F, Miceli-Richard C, Ittah M, Gottenberg J, Sellam J, Mariette X. Augmentation paradoxale de BAFF après déplétion lymphocytaire B induite par le rituximab dans les maladies auto-immunes systémiques Revue Du Rhumatisme. 73: 1092. DOI: 10.1016/J.Rhum.2006.10.171 |
0.779 |
|
| 2006 |
Miceli-Richard C, Comets E, Verstuyft C, Loiseau P, Tamouza R, Ravaud P, Kupper H, Becquemont L, Charron P, Mariette X. Un haplotype du gène du TNF alpha influence la réponse à l'adalimumab chez les patients atteints de polyarthrite rhumatoïde Revue Du Rhumatisme. 73: 1060. DOI: 10.1016/J.Rhum.2006.10.088 |
0.512 |
|
| 2006 |
Pham T, Guillemin F, Claudepierre P, Luc M, Miceli-Richard C, Fautrel B, de Bandt M, Breban M, Goupille P, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, Wendling D, Mariette X, et al. TNFα antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology {lozenge, open}{lozenge, open}Pour citer cet article, utiliser ce titre en anglais et sa référence dans le même volume de Joint Bone Spine. | Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα dans la spondylarthrite ankylosante et le rhumatisme psoriasique Revue Du Rhumatisme (Edition Francaise). 73: 936-943. DOI: 10.1016/J.Rhum.2006.02.014 |
0.561 |
|
| 2005 |
Tubach F, Salmon-Céron D, Ravaud P, Mariette X. The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TnFalpha therapy. Joint Bone Spine. 72: 456-60. PMID 16311059 DOI: 10.1016/J.Jbspin.2005.10.004 |
0.309 |
|
| 2005 |
Terrier B, Lavie F, Miceli-Richard C, Azria A, Mariette X. Focal myositis with fasciitis and vasculitis revealing chronic lymphocytic leukaemia. Rheumatology (Oxford, England). 44: 1324-6. PMID 15941726 DOI: 10.1093/Rheumatology/Keh706 |
0.711 |
|
| 2005 |
Ittah M, Gottenberg JE, Proust A, Hachulla E, Puechal X, Loiseau P, Mariette X, Miceli-Richard C. No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome. Genes and Immunity. 6: 457-8. PMID 15933742 DOI: 10.1038/sj.gene.6364229 |
0.772 |
|
| 2005 |
De Bandt M, Sibilia J, Le Loët X, Prouzeau S, Fautrel B, Marcelli C, Boucquillard E, Siame JL, Mariette X. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Research & Therapy. 7: R545-51. PMID 15899041 DOI: 10.1186/Ar1715 |
0.377 |
|
| 2005 |
Salliot C, Lavie F, Azria A, Clerc D, Miquel A, Mariette X. Retroperitoneal fibrosis secondary to spondylodiscitis after infection with Prevotella. The Journal of Rheumatology. 32: 957-8. PMID 15868637 |
0.597 |
|
| 2005 |
Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, Taoufik Y, Mariette X. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. Journal of Autoimmunity. 24: 235-42. PMID 15848046 DOI: 10.1016/J.Jaut.2005.01.015 |
0.661 |
|
| 2005 |
Gottenberg JE, Busson M, Cohen-Solal J, Lavie F, Abbed K, Kimberly RP, Sibilia J, Mariette X. Correlation of serum B lymphocyte stimulator and β2 microglobulin with autoantibody secretion and systemic involvement in primary Sjögren's syndrome Annals of the Rheumatic Diseases. 64: 1050-1055. PMID 15640273 DOI: 10.1136/Ard.2004.030643 |
0.677 |
|
| 2005 |
Mariette X. Emerging biological therapies in rheumatoid arthritis. Joint Bone Spine. 71: 470-4. PMID 15589425 DOI: 10.1016/J.Jbspin.2004.07.008 |
0.339 |
|
| 2004 |
Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, ... ... Mariette X, et al. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Annals of the Rheumatic Diseases. 64: 913-20. PMID 15550531 DOI: 10.1136/Ard.2004.029694 |
0.322 |
|
| 2004 |
Gottenberg JE, Mignot S, Nicaise-Rolland P, Cohen-Solal J, Aucouturier F, Goetz J, Labarre C, Meyer O, Sibilia J, Mariette X. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 64: 114-7. PMID 15231509 DOI: 10.1136/Ard.2003.019794 |
0.321 |
|
| 2004 |
Lavie F, Miceli-Richard C, Quillard J, Roux S, Leclerc P, Mariette X. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome. The Journal of Pathology. 202: 496-502. PMID 15095277 DOI: 10.1002/Path.1533 |
0.771 |
|
| 2004 |
Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, Combe B, Puéchal X, Pennec Y, Sauvezie B, Perdriger A, Hayem G, Janin A, Sibilia J. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis and Rheumatism. 50: 1270-6. PMID 15077311 DOI: 10.1002/Art.20146 |
0.325 |
|
| 2004 |
Gottenberg JE, Busson M, Loiseau P, Dourche M, Cohen-Solal J, Lepage V, Charron D, Miceli C, Sibilia J, Mariette X. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome. Arthritis and Rheumatism. 50: 570-80. PMID 14872501 DOI: 10.1002/Art.20060 |
0.316 |
|
| 2004 |
Gottenberg JE, Roux S, Assayag P, Clerc D, Mariette X. Specific cardiomyopathy in lupus patients: report of three cases. Joint Bone Spine. 71: 66-9. PMID 14769525 DOI: 10.1016/S1297-319X(03)00101-5 |
0.329 |
|
| 2004 |
Gottenberg J, Roux S, Assayag P, Clerc D, Mariette X. Cardiomyopathies spécifiques au cours du lupus érythémateux systémique : à propos de 3 cas Revue Du Rhumatisme. 71: 78-81. DOI: 10.1016/S1169-8330(03)00274-6 |
0.305 |
|
| 2004 |
Mariette X. Le lymphocyte B : une nouvelle cible thérapeutique dans la polyarthrite rhumatoïde et les maladies auto-immunes Revue Du Rhumatisme. 71: 729-733. DOI: 10.1016/J.Rhum.2003.12.009 |
0.3 |
|
| 2003 |
Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, Sibilia J, Mariette X. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis and Rheumatism. 48: 2240-5. PMID 12905478 DOI: 10.1002/Art.11103 |
0.347 |
|
| 2003 |
Gottenberg JE, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautrel B, Combe B, Durbach A, Sibilia J, Dougados M, Mariette X. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy. Arthritis and Rheumatism. 48: 2019-24. PMID 12847696 DOI: 10.1002/Art.11163 |
0.302 |
|
| 2003 |
Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Annals of the Rheumatic Diseases. 62: 168-71. PMID 12525388 DOI: 10.1136/Ard.62.2.168 |
0.699 |
|
| 2003 |
Mariette X. Current and potential treatments for primary Sjögren's syndrome. Joint Bone Spine. 69: 363-6. PMID 12184431 DOI: 10.1016/S1297-319X(02)00411-6 |
0.324 |
|
| 2002 |
Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood. 99: 3909-15. PMID 12010788 DOI: 10.1182/Blood.V99.11.3909 |
0.352 |
|
| 2002 |
Aractingi S, Sibilia J, Meignin V, Launay D, Hachulla E, Le Danff C, Janin A, Mariette X. Presence of microchimerism in labial salivary glands in systemic sclerosis but not in Sjögren's syndrome. Arthritis and Rheumatism. 46: 1039-43. PMID 11953982 DOI: 10.1002/Art.10137 |
0.337 |
|
| 2002 |
Mariette X, Sibilia J, Roux S, Meignin V, Janin A. A new defensive mechanism to prevent apoptosis in salivary ductal cells from patients with Sjögren's syndrome: over-expression of p53 and p21. Rheumatology (Oxford, England). 41: 96-9. PMID 11792886 DOI: 10.1093/Rheumatology/41.1.96 |
0.321 |
|
| 2002 |
Mariette X. Les syndromes secs médicamenteux Revue Du Rhumatisme. 69: 386-389. DOI: 10.1016/S1169-8330(02)00313-7 |
0.312 |
|
| 2001 |
Mariette X. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Annals of the Rheumatic Diseases. 60: 1007-10. PMID 11602464 DOI: 10.1136/Ard.60.11.1007 |
0.343 |
|
| 2000 |
Mariette X, Brouet JC, Chevret S, Leger JM, Clavelou P, Pouget J, Vallat JM, Vial C. A randomised double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM. Journal of Neurology, Neurosurgery, and Psychiatry. 69: 279-80. PMID 10960293 DOI: 10.1136/Jnnp.69.2.279 |
0.307 |
|
| 1997 |
Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela J, Soussi T, Maloisel F, Clauvel J, Brouet J, Mariette X. Lymphomas in Patients With Sjögren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses Blood. 90: 766-775. DOI: 10.1182/Blood.V90.2.766 |
0.327 |
|
| 1996 |
LELIEVRE J, CHEROT P, AGBALIKA F, MARIETTE X. Etude de la présence et de l'expression du gène pX du virus HTLV-1 chez des patients porteurs d'un syndrome de Goujerot-Sjögren MéDecine Et Maladies Infectieuses. 26: 875-878. DOI: 10.1016/S0399-077X(96)80271-X |
0.319 |
|
| 1995 |
Mariette X, Cherot P, Cazals D, Brocheriou C, Brouet JC, Agbalika F. Antibodies to HTLV-I in Sjögren's syndrome. Lancet (London, England). 345: 71. PMID 7865009 DOI: 10.1016/S0140-6736(95)91200-2 |
0.309 |
|
| 1993 |
Mariette X, Agbalika F, Daniel MT, Bisson M, Lagrange P, Brouet JC, Morinet F. Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjögren's syndrome. Arthritis and Rheumatism. 36: 1423-8. PMID 8216402 DOI: 10.1002/Art.1780361015 |
0.312 |
|
| 1991 |
Clerc D, Brousse C, Mariette X, Bennet P, Bisson M. Cytomegalovirus pneumonia in a patient with rheumatoid arthritis treated with low dose methotrexate and prednisone. Annals of the Rheumatic Diseases. 50: 67. PMID 1847283 DOI: 10.1136/Ard.50.1.67-B |
0.308 |
|
| 1991 |
Mariette X, Gozlan J, Clerc D, Bisson M, Morinet F. Detection of Epstein-Barr virus DNA by in Situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome The American Journal of Medicine. 90: 286-294. DOI: 10.1016/0002-9343(91)90567-H |
0.309 |
|
| Show low-probability matches. |